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Abstract
Pharmaceuticals and Personal Care Products (PPCPs) is a category of
compounds where are included pharmaceutical drugs, cosmetic ingredients, food
supplements, shampoos, lotions and sunscreens cosmetics. These products contain a
number of organic compounds such as UV-filters, fragrances, antimicrobials,
preservatives and insect repellants also collectively referred as PPCPs. PPCPs have
been found in surface water such as lakes, rivers and sea, waste water and tap water and
also in bathing water and swimming pool water. Disinfection of swimming pool water is
essential to inactivate pathogenic microorganisms. However chlorine based disinfectants,
the most commonly used, react with the organic matter present in water leading to the
formation of disinfection byproducts (DBPs) which are known to be associated to adverse
health effects. PPCPs may also suffer transformation/degradation caused by sunlight UV
radiation. The present study aims improve the knowledge about the transformations of
UV-filters occurred in swimming pools. The present work had two major objectives: (i) the
assess of the stability of four UV-filters (benzyl salicylate, phenyl salicylate, 4-methyl
benzilydene camphor and octocrylene) in chlorinated water, (a) evaluating their stability in
water samples with different pH values and different free chlorine conditions; (b) to
determine their half-lives; (c) tentatively identify the major DBPs and (d) to study their
stability under time, and (ii) assess the toxicity of another UV-filter (4-methoxy-4`-tert-
butyldibenzoylmethane) comparing the toxicity caused by the parental compound to the
toxicity of its DBPs acutely exposing larvae of zebrafish (Danio rerio) to several
concentrations of 4-methoxy-4`-tert-butyldibenzoylmethane and corresponding DBPs
solution. The effect of these compounds regarding mortality and anatomic abnormalities
was assessed. The reactions between the UV-filters and chlorine were followed by HPLC-
MS. Benzyl salicylate and phenyl salicylate reacted with chlorine yielding three DBPs
each one. 4-methyl benzilydene camphor and octocrylene were found to be stable under
the experimental conditions used. It was not possible to conclude if 4-methoxy-4`-tert-
butyldibenzoylmethane and its DBPs at 1 mg/L have impact on the larvae although it was
observed some abnormalities at 0.1 mg/L of DBPs.
Keywords: UV-filters, personal care products, chlorination, chlorinated byproducts,
benzyl salicylate, phenyl salicylate, 4-methyl-benzylidene camphor, 4-methoxy-4`-tert-
butyldibenzoylmethane, zebrafish
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vResumo
Produtos farmacêuticos e outros produtos de cuidado corporal (PPCPs, do Inglês
Pharmaceuticals and Personal Care Products) são uma categoria de produtos que inclui
fármacos, ingredientes de cosméticos, suplementos alimentares, champôs, loções,
protectores solares entre outros. Estes produtos contêm vários compostos orgânicos
como filtros UV, fragrâncias, compostos com propriedades antimicrobianas, conservantes
e repelentes de insecros que se incluem também na categoria de PPCPs. Vários PPCPs
têm sido encontrados em águas de superfície como lagos, rios e mar, águas de esgoto,
água da torneira, bem como também em águas de piscina. A desinfecção da água das
piscinas é fundamental para inactivar os microrganismos patogénicos. No entanto, os
desinfectantes à base de cloro, que são os mais usados, reagem com a matéria orgânica
presente na água levando à formação de produtos de desinfecção (DBPs, do Inglês
Disinfection Byproducts) que podem estar associados a efeitos nefastos para a saúde.
PPCPs também podem sofrer transformações resultantes da exposição à radiação UV
solar. Este estudo visa aumentar o conhecimento sobre os processos de transformação
sofridos pelos filtros UV em piscinas. Os seus dois maiores objectivos passam por (i)
avaliar a estabilidade de quatro filtros UV (benzil salicilato, fenil salicilato, 4-
metilbenzilideno cânfora e octocrileno) em água clorada (a) avaliando a sua estabilidade
sob diferentes valores de pH e diferentes concentrações de cloro, (b) determinando os
tempos de semi-vida, (c) identificando os principais DBPs (d) estudando a sua
estabilidade ao longo do tempo, e (ii) avaliar a toxicidade de um outro filtro UV (4-metoxi-
4`-tert-butildibenzoilmetano) comparando a toxicidade causada pelo composto parental
com a toxicidade causada pelos seus DBPs, expondo de forma aguda larvas de peixe-
zebra (Danio rerio) a várias concentrações de 4-metoxi-4`-tert-butildibenzoilmetano e
correspondentes DBPs. Os efeitos destes compostos foram avaliados ao nível da
mortalidade e malformações. As reacções entre os filtros UV e o cloro foram seguidas por
HPLC-MS. Benzil salicilato e fenil salicilato reagiram com o cloro formando três DBPs
cada um. 4-metilbenzilideno cânfora e octocrileno mantiveram-se estáveis sob as
condições experimentais usadas. Não foi possível concluir se 4-metoxi-4’-tert-
butildibenzoilmetano e os seus DBPs tiveram impacto nas larvas à concentração de 1
mg/L apesar de se ter observado alguma mal formações a concentrações de 0.1 mg/L
dos DBPs.
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1Chapter I
Introduction
2
31. Introduction
1.1. Motivation
Pharmaceuticals and Personal Care Products (PPCPs) is a category of
compounds where are included pharmaceutical drugs, cosmetic ingredients, food
supplements and other products like shampoos, lotions and sunscreens cosmetics (Shen
and Andrews, 2011). Sunscreens cosmetics are any cosmetic which contains UV-filters in
its formulation to protect human skin from the solar UV radiation since they absorb, reflect
and/or scatter UV radiation with a wavelength between 320 and 400 nm for UVA and
between 290 and 320 nm for UVB (Negreira et al., 2008; Salvador and Chisvert, 2005;
Santos et al., 2012).
PPCPs have been found in surface water such as lakes, rivers and sea, waste
water and tap water (Giokas et al., 2004; Poiger et al., 2004; Sui et al., 2011; Westerhoff
et al., 2005). In the case of pharmaceuticals the main reason for this is that during the
wastewater treatment, the parental compounds are not totally removed and, in several
cases, they also suffer biodegradation and biotransformation (Onesios and Bouwer,
2009). Then, the release of the effluents in the environment leads to the occurrence of
PPCPs and derivatives in the locations above mentioned. PPCPs have been also found in
bathing waters and swimming pool water due their use by swimmers (Lakind, 2010) by
washing bath effect during bathing and swimming activities (Santos et al., 2012). The
problem is that, as in drinking water, the chlorine used in the disinfection process reacts
with these compounds generating chlorinated byproducts (DBPs) that may possess
enhanced toxicity (Buth et al., 2007; Lakind, 2010, Richardson et al., 2010).
Since UV-filters are designed to absorb a large amount of solar energy, it is
probable that their fate in natural waters is controlled by solar mediated mechanisms.
However, the information in the literature about photochemistry of UV-filters in illuminated
aqueous solutions and in natural waters is still limited.
Some of them have estrogenic activity (Morohoshi et al., 2005; Kunz and Fent,
2006) and are phytotoxic (Rodil et al., 2009) with their toxicity altered by solar irradiation
(Rodil et al., 2009, Hayashi et al., 2006). Some UV-filters can photogenerate reactive
oxygen species (ROS) (Allen et al., 1996a; Allen et al., 1996b; Inbaraj et al., 2002) that
may damage biomacromolecules. For example, phenyl benzimidazole sulfonic acid
(PBSA), a widely used UV-filter, can photogenerate 1O2 and O2-˙ (Inbaraj et al., 2002)
causing DNA damage (Stevenson and Davies, 1999). So, it is important to understand the
4photochemical behavior and fate of sunscreens to assess their ecological risk (Zhang et
al., 2010).
1.2. Goals
The present work had two major objectives: (i) the assess the stability of four UV-
filters commonly used in personal care products (PCPs): benzyl salicylate (BzS), phenyl
salicylate (PS), 4-methyl benzilydene camphor (4-MBC) and octocrylene (OC) in
chlorinated water, in conditions similar to those existent in swimming pools, (a) evaluating
their stability in water samples with different pH values and different free chlorine
conditions; (b) to determine their half-lives; (c) tentatively identify the major DBPs and (d)
to study their stability under time, and (ii) assess the toxicity of an UV-filter whose
chlorination reaction was already studied by Santos et al., (Santos et al., 2013) (4-
methoxy-4’-tert-butyldibenzoylmethane - BDM) comparing the toxicity caused by the
parental compound to the toxicity of its DBPs acutely exposing larvae of zebrafish (Danio
rerio) to several concentrations of BDM and corresponding DBPs solution resulting from
chlorination reaction. The effect of these compounds regarding mortality and anatomic
abnormalities was assessed. This toxic assay was performed on an experimental basis
giving a first approach on the study of BDM´s toxicity.
1.3. Structure of the thesis
The present thesis is subdivided in six chapters:
 Chapter I: where the motivation, main goals and the structure of the thesis
are introduced.
 Chapter II: State of the Art, where is presented a review of the literature
about the presence of PPCPs in chlorinated waters, the reaction between
them and chlorine and the environmental and health impacts of PPCPs and
their DBPs. In this part, is present a book chapter (Occurrence of Personal
Care Products and Transformations Process in Chlorinated Waters)
published in The Handbook of Environmental Chemistry by Springer Berlin
Heidelberg, 20014 (DOI: 10.1007/698_2014_263). This chapter is an
introduction of all the present work. The references of this chapter are at
the final of this part.
5 Chapter III: Study of the transformation of two salicylates used in personal
care products in chlorinated water, a paper (DOI:
10.1016/j.watres.2014.07.018) published with the results about the
chlorination of two UV-filters: BzS and PS. This chapter is subdivided in
Introduction, Material and Methods, Results and Discussion and
References.
 Chapter IV: Study of the transformation of 4-MBC and OC in chlorinated
water and by UV radiation. Here, the degradation of these UV-filters by
chlorine and UV-radiation is assessed. This chapter is subdivided in
Introduction, Material and Methods, Results and Discussion and
References
 Chapter V: Toxicological assays – A first approach, where the toxic effects
of another UV-filter (BDM) and its DBPs is assessed in larvae of zebrafish
(Danio rerio). This chapter is subdivided in Introduction, Material and
Methods, Results and Discussion and References
 Chapter VI: Conclusions, where are the conclusions of all the results of the
present work.
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2.1. UV-filters chlorination
The following chapter was written in response to the invitation from Springer
International Publishing Switzerland to the group of Professor Joaquim Carlos Gomes
Esteves da Silva. The design of the structure and the selection of the topics covered were
conducted by the three authors of the publication according to the publisher suggestion to
address the topic of “occurrence of personal care products and transformation process in
chlorinated waters”. The text was written by the author Mariana M. de Oliveira e Sá. The
supervision, revisions and suggestions of improvement were added by Margarida S.
Miranda and Joaquim C. G. Esteves da Silva.
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2.2. Pharmaceuticals chlorination
Besides sunscreens, others PPCPs such as pharmaceuticals may also be present
in pool water.
For instance, the antimicrobial triclosan is used in hygienic products like soaps
and bodywash and can therefore be released into water during swimming activities. When
it comes into contact with chlorine, triclosan suffers chlorination yielding several
byproducts (Fiss et al., 2007). Chloroform and chlorophenol are the two DBPs formed
from triclosan chlorination, however they appear only under specific conditions. The
chlorophenol yields are inversely correlated with the chloroform yields. Fiss et al. (Fiss et
al., 2007) observed that in unfavorable conditions for chloroform formation, in addition to
chlorophenol it is also released intermediate (chlorophenoxy)phenols: 5,6-dichloro-2-(2,4-
dichlorophenoxy)phenol, 4,5-dichloro-2-(2,4-dichlorophenoxy)phenol and 4,5,6-trichloro-2-
(2,4-dichlorophenoxy)phenol). This happens maybe because chloramines are formed due
to the presence of another soups’s ingredients, like ammonium salt. Those chloramines
react with triclosan producing chlorophenols and (chlorophenoxy)phenols, but have
insufficient oxidizing power to cleave the phenol ring of triclosan and produce chloroform.
So, chloroform is only yielded when a sufficient excess of free chlorine is present to
cleave the phenol ring of triclosan. Again, the soap composition may affect the amount of
free chlorine because the other ingredients also suffer chlorination (Fiss et al., 2007).
Antipyrine (ANT) is a pharmaceutical and has anti-inflammatory and analgesics
properties. It was already found in several aquatic environments because it cannot be
removed completely during water and wastewater treatments (Cai et al., 2013a; Cai et al.,
2013b). So, ANT appears in drinking water and, subsequently, in pool water. Then,
reaction between chlorine and this pharmaceutical can occur. Cai et al. (Cai et al., 2013b)
identified sixteen chlorination by-products including a monochlorine substitution product
(4-chloro-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one) called ANT-Cl, which
results from halogenation by free chlorine attack (Fig.2.1) (Cai et al., 2013a; Cai et al.,
2013b). The potential pathways of ANT chlorination were proposed, including
halogenations, dealkylations and hydroxylations (Cai et al., 2013b). But pharmaceutical
chlorination is also regulated by some factors, such as initial chlorine concentration and
pH. For instance, ANT chlorination reaction is faster when pH is lower than 7 (Cai et al.,
2013a) and increases with initial chlorine concentration increasing (Cai et al., 2013b).
Cimetidine, another pharmaceutical found in the environment, reacts with chlorine
(Fig.2.2) during water treatment yielding other DBPs which were already characterized.
Given its structure, cimetidine chlorination may be expected to result in minor structural
changes such as sulfur oxidation, electrophilic halogenation and N-chlorination of one or
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more of its amino groups. Excess of free chlorine gives rise to cimetidine sulphoxide
(C10H16N6SO) and then to 4-hydroxymethyl-5-methyl-1H-imidazole which forms an ion - 5-
methyl-4-methylene-1H-imidazol-1-ium – through loss of water (Fig.2.3). From this latter, it
can be formed another intermediate - 4-chloro-5-methyl-1H-imidazole – but this requires
the breaking of a C-C bound, a transformation not frequently observed in free chlorine
reactions of PPCPs. Finally, it is formed a byproduct with chemical structure C5H8N4O2S
(Buth et al., 2007). Buth et al. (Buth et al., 2007) failed to distinguish by the mass
spectrometric or spectroscopic data if this compound was a β-sultam, N-cyano-N’-methyl-
N’’-β-sultamylguanidine, or a δ-sultam, N-(2-methyl-1,1-dioxide-1,2,4-thiadiazinan-3-
ylidene)cyanamide.
Figure 2.1. In the process of ANT chlorination, free chlorine can attack ANT to bring about
halogenation. Adapted from Cai et al., 2013a and Cai et al., 2013b.
Cimetidine chlorination is also regulated by pH: the entire reaction pathway shown
in Figure 7 with all its steps and intermediates may occur at acidic and neutral pH,
whereas the direct conversion of cimetidine to 4-hydroxymethyl-5-methyl-1H-imidazole, 4-
chloro-5-methyl-1H-imidazole and β-sultam, N-cyano-N’-methyl-N’’-β-sultamylguanidine/δ-
sultam, N-(2-methyl-1,1-dioxide-1,2,4-thiadiazinan-3-ylidene)cyanamide bypassing
cimetidine sulfoxide, may occur under basic conditions (Buth et al., 2007).
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Figure 2.2. Reaction pathways for the cimetidine chlorination through the intermediacy of
cimetidine sulfoxide proposed by Buth et al., 2007)
Figure 2.3. The detected ion 5-methyl-4-methylene-1H-imidazol-1-ium, resulting from the loss of
water from 4-hydroxymethyl-5-methyl-1H-imidazole.
The chlorination of diclofenac, bezafibrate, salicylic acid, clofibric acid, naproxen,
indomethacine, ketoprofen, ibuprofen and fenoprofen has also already been studied.
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These pharmaceuticals are among the most frequently found in the environmental by the
same reasons as above and they also suffer chlorination when they are present in tap
water (Quintana et al., 2010). In 2010, Quintana et al. (Quintana et al., 2010) studied their
degradation in chlorinated water but only salicylic acid, diclofenac, naproxen and
indomethacine were further evaluated because they were the only ones that had
degradation over 30%. In this study, it was verified that as the chlorine concentration
increases, the reaction kinetics accelerates. Chlorination of salicylic acid yielded three
DBPs due to halogenation in the ring activated positions 3 and 5: two isomers of
chlorosalicylic (3-Cl-SA and 5-Cl-SA) acid and 3,5-dichlorosalicylic acid (Cl2-SA). About
chlorination of naproxen, chloronaproxen (Cl-naproxen) is formed. Diclofenac formed a
monochlorinated byproduct (Cl-diclo) and another product (Cl-diclo-CO) which empirical
formulae corresponding to the loss of a CO group from the first one. Cl-diclo-CO is
probably formed through a lactone intermediate by decarboxylation and oxidation of the
dichlorinated ring in position 4. In the case of Cl-diclo, it suffers losses of CO2 and HCl.
Regarding indomethacine, HOCl does not leads to halogenation but to oxidation as the
monochlorination pattern of the deprotonated products is maintained. The major products
from this reaction are two hydroxylated isomers (OH-indo) formed due to the losses of
CO2 and CO. Two decarboxylated hydroxylated products (OH-indo-CO2) are also
produced, as well as, two other minor products whose correspond to desahydro-
indomethacine (indo-H2) and 4-chlorobenzoic acid (Cl-BA), probably produced by the final
hydrolysis of the amine group.
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Figure 2.4. DBPs of salicylic acid, naproxen, diclofenac and indomethacine proposed by
Canosa et al., 2006
It is important to monitor the concentrations and the environmental behavior of
these compounds. The complexity of the matrices and the fact that UV-filters are usually
at trace concentrations levels require methods with enough sensitivity to report
concentrations at the ng/L level. Methods based in liquid chromatography (LC) are a god
separation technique although gas chromatography (GC) has recently been found as
more powerful and faster. Mass spectrometry (MS) is the detection technique most
frequently used and, due to the high absorbance of UV-filters in the UV range, UV/Vis
spectrometry detector is useful, either with single-wavelength or with diode-array detection
(DAD) attached to a LC system (Díaz-Cruz and Barceló, 2009).
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4. Study of the transformation of 4-MBC and OC in chlorinated water and by
UV radiation
4.1. Photodegradation of UV-filters
Besides the reaction between chlorine and UV-filters described above (Chapter II),
these compounds may also suffer transformation induced by sunlight.
These photochemical reactions are one of the most important abiotic processes
determining the aquatic fate of organic compounds in natural waters (Rodil et al., 2009). It
is important that UV-filters are stable under sunlight exposure because a high screening
efficiency is only guaranteed if the UV-filter has high stability (Santos et al., 2012; Rodil et
al., 2009). In a commercial formula of sunscreen, these photostability depends not only on
the UV-filter but also of the presence of other UV-filters, other active substances, like
antioxidants (Gaspar and Maia Campos, 2007). However, several papers have been
published reporting photodegradation of some UV-filters. In 2006, Gaspar and Campos
(Gaspar and Maia Campos, 2006) analyzed the photostability of four different UV-filters
combinations after UVA and UVB irradiations: EHMC, BP3 and octyl salicylate (OS)
(formulation 1); EHMC, BDM and 4-MBC (formulation 2); EHMC, BP3 and OC
(formulation 3); and EHMC, BDM and OC (formulation 4). They studied UV-filters
formulations instead individual UV-filters because the behavior of sunscreens is not
predictable from the photostability of its individual filter but from the behavior of their UV-
filters combinations (Gaspar and Maia Campos, 2006). So, they observed that, in terms of
EHMC recovery, formulation 3 was the most stable, followed by formulation 4, formulation
1 and formulation 2. In terms of BDM recovery formulation 4 was more stable than
formulation 2, and regarding BP3 recovery formulation 3 was more stable than formulation
1. In terms of OC recovery, formulation 3 was more stable than formulation 4. It was
observed that BDM and EHMC react with each other during irradiation time forming
cycloaddition products and maybe other photoadducts, fact that may explain why
formulation 3 was more stable than formulations 4 and 2. In this study, it was also
observed that OC and 4-MBC can stabilize BDM, OC is very effective in stabilizing EHMC
in presence of BDM and OC is good UV stabilizer, since formulation 3, which contained
EHMC, BP3 and OC, was more stable than formulation 1, which contained EHMC, BP3
and OS.
Concerning BDM, Huong et al. (Huong et al., 2008) observed that, under
irradiation in aqueous solution, the enol form tautomerizes to the keto form and is also
fully degraded. Substituted benzoic acids, benzils, dibenzoylmethanes and dibenzoyl
ethanes were the photoproducts found by Huong et al. (Huong et al., 2008).
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In 2003, Sakkas et al. (Sakkas et al., 2003) studied photodegradation of another
UV-filter: EHDPABA. In this study, differently to the paper referred above,
photodegradation was analyzed in different types of water: distilled, chlorinated pool and
seawater. It was observed that reaction rates followed the order: distilled water>swimming
pool water>seawater. After 60h of natural irradiation (daylight exposure) 86, 83 and 80%
of this UV-filters as degraded in distilled, swimming pool and seawater, respectively.
However, simulated solar irradiation was more effective in EHDPABA: only 10h were
enough to degrade more than 99, 96 and 92%, respectively. It was also observed that the
presence of organic matter like humic acids inhibits the photodegradation rate of
EHDPABA. This retardation on the degradation rate occurs maybe due to a competition
process between organic matter and the UV-filter for the available photons. Incident light
scattered by particulate matter suspended in the water column and a partial binding
between organic matter and EHDPABA by hydrophobic partitioning or weak van der
Waals forces which causes a fraction that will never be available to photolysis action are
another reasons to the retardation on photodegradation rate. In seawater, this is also
consistent with •OH scavenging by chloride ions.
Rodil et al. (Rodil et al., 2009) analyzed the stability of six UV-filters exposed to
artificial sunlight in water: BP3, ethylexyl methoxycinnamete (EHMC), isoamyl
methoxicinnamte (IAMC), EHDPABA, OC and 4-MBC. Half-lives and phototransformation
products of these UV-filters were identified. And they observed that BP3, OC and 4-MBC
are very photostable, while EHMC, IAMC and EHDPABA clearly showed
photodegradation. It was also observed a fast E to Z isomerization of EHMC, IAMC and 4-
MBC. This isomerization phenomenon was confirmed as a way to reduce the absorber UV
energy. Isomerization of EHMC was previously observed by Huong (Huong et al., 2007).
Concerning photodegradation products, Rodil et al. (Rodil et al., 2009) found two
products resulting from dealkylation of EHDPABA, a photodissociation process whereby
the loss of one and two of the methyl groups of EHDPABA occurs, respectively. These
photoproducts showed to be stable for several days. Another compound was also
observed and it was proposed as a methylated derivate of the parent compound. These
photoproducts showed to be stable for several days. On the other hand, no
photodegradation product was detected for EHMC and IAMC.
Few years later Liu et al. (Liu et al., 2011) reported again the significant
photostability of BP3 under both artificial and natural sunlight. However, in this study BP3
was significantly degraded when in contact with another UV-filter (benzotriazole) and with
humic acids in solution. In this case, it was detected one photoproduct produced through
the loss of hydroxyl and benzoyl functional group. This product was determined and
identifies as 2,4-dimethylanisole.
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The photostability of p-aminobenzoic acid (PABA), EHDPABA, EHMC, BP3, PBSA
in different solvents was studied by Serpone et al. (Serpone et al., 2002): water, methanol,
acetonitrile and n-hexane, under aerobic and anaerobic conditions. It was observed that in
both types of solvents (aqueous and non-aqueous) PABA had an extensive
photodegradation: 87%, 65%, 60% and 45% in n-hexane, water, methanol and acetonitrile
respectively. On the other hand EHDPABA had a higher degradation in n-hexane (97%)
followed by acetonitrile (94%), water (75%) and methanol (15%). Regarding
photodegradation of EHMC, 90% of this UV-filter was degraded in water, 45% in
acetonitrile and 40% in methanol and in n-hexane. These percentages were obtained after
30 min of UV exposure, however after 2h of UV exposure EHMC degraded in 95% in n-
hexane yielding several photodegradation products. Similar to Rodil et al. (Rodil et al.,
2009) and to Liu et al. (Liu et al., 2011), in this study Serpone et al. (Serpone et al., 2002)
also observed a high stability of BP3 in water (20% of degradation after 2h of UV
exposure) as well as in acetonitrile and n-hexane (5-10% and 15% of degradation,
respectively, after 2h of UV exposure). However, in methanol BP3 was particularly
unstable, photodegrading almost completely (90%) after 2 h. Finally, PBSA showed a high
insolubility in n-hexane but its degradation was very fast in water (90% after only 10 min of
UV exposure). In acetonitrile the degradation was nearly by 50% after only 20 min of UV
exposure and 70% complete after 2 h. The degradation was also significant in methanol.
Serpone et al. (Serpone et al., 2002) also observed that PABA, EHDPABA, EHMC
and BP3 have a faster degradation under aerobic than under anaerobic conditions: 60%
vs. 55% after 1h for PABA, 55% vs. 20% after 10 min for EHDPABA, 85% vs. 65% after
20 min for EHMC, and 50% vs. 15% after 260 min for BP3, respectively. This happens
because oxygen is converted in some reactive oxygen species. In the case of PABA, this
UV-filter is a good photosensitizer when exposed to UV radiation yielding molecular
oxygen. PABA is also a good sink for these reactive oxygen species which causes PABA
self-destruction.
In 2010, Zhang et al. (Zhang et al., 2010) confirmed that PBSA photodegradates
under artificial UV radiation in aqueous solution and they identified several photodegration
products in pure water: a desulfonated product (2-phenylbenzoimidazole), three products
formed from the cleavage of the benzene ring adjacent to the imidazole ring
(phenylimidazolecarboxylic acid derivatives) and two compounds produced from the
opening of the imidazole ring (benzimidamide and benzamide).
The aim of this step was: (i) assess the stability of 4-MBC and OC in chlorinated
water, in conditions similar to those existent in swimming pools, and (ii) assess the
stability of 4-MBC and OC under artificial and natural UV radiation.
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4.2. UV-filters under study
4-MBC is an UV-filter used in many PCPs like sunscreens, lotions and shampoos
being one of the most commonly used UV-filters (Buser et al., 2005). This UV-filter is one
of the authorized UV filters in Europe and Australia and has been submitted for approval
in the USA (Scalia et al., 2007). It absorbs in UVB region (290-320 nm) (Giokas et al.,
2007; Scalia et al., 2007) and can exist as a cis- (Z) and trans- (E) isomer due to exocyclic
carbon-carbon double bound (Fig.4.1). Although only the E-form is present in commercial
products, both isomers can be found in environmental samples (Buser et al., 2005). 4-
MBC has a good photostabilizer effect in the sunscreens formulations.
OC is another UV-filter introduced in sunscreens products approximately 14 years
ago (Avenel-Audran et al., 2014). This UV-filter is an ester (Fig.4.2) formed by the
condensation of a diphenylcyanoacrylate with 2-ethylhexane (Avenel-Audran et al., 2014)
and it absorbs in UVB region (390-360 nm) (González et al., 2008). OC has been
increasingly used due to its spectrum efficiency covering UVB but also short UVA
wavelengths (Avenel-Audran et al., 2014). It is photostable (González et al., 2008) and it
is also used as photostabilizer in sunscreens formulations (Palm and O’Donoghue, 2007).
Figure 4.1. Structure formula of 4-MBC.
Figure 4.2. Structure formula of OC.
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4.3. Materials and Methods
4.3.1. Reagents
4-MBC, CAS Registry No. [36861-47-9], 98%, (molecular formula C18H22O) was
purchased from Sigma-Aldrich. OC, CAS Registry No. [6197-30-4], 98%, (molecular
formula C24H27O2) was purchased from Aako. A commercial sodium hypochlorite solution
with a chlorine content of <5% (28 mg/L of free chlorine) was used in the chlorination
studies. This solution was stored at 4ºC and its free chlorine content was periodically
measured by a small compact photometer for chlorine (HANNA Checker Mini Hi 701
series). Stock solutions of the UV-filters were prepared with methanol from Merck.
Deionized water (conductivity < 0.1 S cm-1) was used in all experiments. Ascorbic acid
(99.7%) used to stop the chlorination reaction was obtained from Merck. The pH of the
solutions was adjusted to a pre-determined value with HCl solutions 0.1 mol/L. Eluents for
chromatographic analysis (methanol and acetonitrile) were liquid chromatographic grade
and were bought from Merck.
4.3.2. Study of the reaction kinetics of 4-MBC and OC in chlorinated water
For this study stock solutions of the two UV-filters in methanol (about 100 mg/L)
were first prepared. The kinetics of the reactions was evaluated at room temperature:
(20.0 ± 1.0)ºC. The reactions were carried out in glass vessels containing 100 mL of
deionized water. At first, the deionized water samples were spiked with free chlorine to get
the initial concentration of 10 mg/L for the two UV-filters. After that, the pH of the aqueous
solution was adjusted to (7.0 ± 0.1) with 0.1 mol/L HCl and the resulting solution was then
spiked with the stock solutions of the UV-filters in methanol (experiments were performed
separately for each one) to get the concentration of 1 mg/L (ratio UV-filter:chlorine 1:10).
These experimental conditions were chosen with the intent to mimic swimming pool
conditions and allow the development of pseudo-first order conditions (Deborde and Von
Gunten, 2008). These solutions were kept in the dark and were stirred during the whole
experiment. At fixed reaction times (every 20 min for 4-MBC; and from 20 to 4162 min for
OC) an aliquot of the reaction mixture was taken, the excess of chlorine was quenched
with ascorbic acid according the stoichiometric relationship of 2.5 parts of ascorbic acid to
1 part of free chlorine, and the samples were then immediately analyzed by HPLC-UV-
DAD. A blank solution with only the UV-filter (without chlorine) was also analyzed.
The ratios UV-filter:chlorine 1:20 and 0.25:1 were also studied for OC.
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4.3.3. Study of the degradation induced by UV radiation of 4-MBC and OC
In a first stage, to study the photodegradation of 4-MBC, a 30 min assay analyzed
by a spectrophotometer Hewlett Packard 8452A Diode Array and also by HPLC-UV-DAD
was conducted. In this step stock solutions of 4-MBC in methanol (about 100 mg/L) were
first prepared. The reactions were carried out under artificial sunlight UV radiation in glass
vessels containing 100 mL of deionized water spiked with the stock solutions of the UV-
filter to get the concentration of 1 mg/L. After that, the pH of the aqueous solution was
adjusted to (7.0 ± 0.1) with 0.1 mol/L HCl. This solution was kept during the whole
experiment under artificial UV radiation provided by a mercury lamp (PHILIPS, HPLR
400W). The distance between the water surface and the lamp was 5.5 cm. The
temperature of the solutions increased during the experiment due to the heat released by
the lamp (from 23.8 ºC to 26.5 ºC). At fixed reaction times (from 10 to 30 min) an aliquot
sample of the reaction mixture was taken and the samples were then immediately
analyzed by spectrophotometer and HPLC-UV-DAD. It was also analyzed a blank solution
with the UV-filter kept in the dark but suffering the same temperature fluctuation.
This 30 min assay was performed also under natural UV radiation. In this case, the
reactions were carried out separately in glass vessels containing 100 mL of deionized
water spiked with the stock solutions of 4-MBC in methanol to get the concentration of 1
mg/L. After that, the pH of the aqueous solution was adjusted to (7.0 ± 0.1) with 0.1 mol/L
HCl. Blank solutions with the UV-filter kept in the dark was also analyzed. At fixed reaction
times (from 10 to 30 min, every 10 min) an aliquot of the reaction mixture was taken and
the samples were then immediately analyzed by spectrophotometer and HPLC-UV-DAD.
To study the behavior of OC under UV radiation, stock solutions of OC in methanol (about
100 mg/L) were first prepared. The reaction was carried out under artificial UV radiation in
glass vessels containing 100 mL of deionized water spiked with the stock solutions of OC
to get the concentration of 0.5 mg/L. After that, the pH of the aqueous solution was
adjusted to (7.0 ± 0.1) with 0.1 mol/L HCl. This solution was kept during 30 min under
artificial UV radiation provided by a mercury lamp with (PHILIPS, HPLR 400W). The
distance between de water surfaces into the glass vessel and the lamp was 5.5 cm. The
temperature of the solutions fluctuated according the increasing of the temperature
caused by the heat of the lamp: (24.0 ± 2.0)ºC. After 30 min of reaction an aliquot sample
of the reaction mixture was taken and was immediately analyzed by spectrophotometer
and HPLC-UV-DAD.
In a second step, stock solutions of 4-MBC and OC in methanol (about 100 mg/L)
were first prepared. The degradation was evaluated at constant temperature (20.0 ±
2.0)ºC ensured by a glass vessel with double walls with water circulating at room
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temperature. The reactions were carried out in 100 mL of deionized water. The deionized
water samples were spiked with the stock solutions of the UV-filters in methanol
(experiments were performed separately for each one) to get the concentration of 1 mg/L.
After that, the pH of the aqueous solution was adjusted to (7.0 ± 0.1) with 0.1 mol/L HCl.
These solutions were kept under artificial UV radiation provided by a mercury lamp
(PHILIPS, HPLR 400W) emitting in the range of UVB (280 to 315 nm) and were stirred
during the whole experiment. The distance between de water surfaces into the glass
vessel and the lamp was 5.5 cm. At fixed reaction times (from 30 to 150 min, every 30 min
for 4-MBC, and from 60 to 240, every 60 min for OC) an aliquot of the reaction mixture
was taken and the samples were then immediately analyzed by HPLC-UV-DAD. A blank
solution with the UV-filter kept in the dark was also analyzed.
In addition to artificial source of UV radiation, studies under natural UV radiation
were also conducted. For these studies stock solutions of 4-MBC and OC in methanol
(about 100 mg/L) were first prepared. The reactions were carried out in glass vessels
containing 100 mL of deionized water spiked with the stock solutions of the UV-filters in
methanol (experiments were performed separately for each one) to get the concentration
of 1 mg/L. After that, the pH of the aqueous solution was adjusted to (7.0 ± 0.1) with 0.1
mol/L HCl. These solutions were kept during the whole experiment under direct natural
UV radiation. In this case, the temperature fluctuated according to the environmental
temperature (between 21 and 28 ºC for 4-MBC and between 24 and 31 ºC for OC). At
fixed reaction times (from 60 to 360 min, every 60 min for 4-MBC, and from 60 to 480,
every 60 min for OC) an aliquot of the reaction mixture was taken and the samples were
then immediately analyzed by HPLC-UV-DAD. It was also analyzed a blank solution with
the UV-filter kept in the dark but suffering the same temperature fluctuation.
There was also tested the effect caused by chlorine in these two steps. In the 30
min assay, chlorine was added only to 4-MBC. The reactions were carried out in glass
vessel containing 100 mL of deionized water. The deionized water samples were spiked
with free chlorine to get the initial concentration of 10 mg/L. After that, the pH of the
aqueous solution was adjusted to (7.0 ± 0.1) with 0.1 mol/L HCl and the resulting solution
was then spiked with the stock solutions of 4-MBC in methanol to get the concentration of
1 mg/L (ratio UV-filter:chlorine 1:10). The solutions were kept under artificial UV radiation
provided by a mercury lamp (PHILIPS, HPLR 400W) emitting in the range of UVB (280 to
315 nm) during the whole experiment and the temperature of the solutions fluctuated
according the increasing of the temperature caused by the heat of the lamp: (24.0 ±
2.0)ºC. The distance between de water surfaces into the glass vessel and the lamp was
5.5 cm. At each 10 min in a reaction time of 30 min an aliquot of the 4-MBC reaction was
taken, the excess of chlorine was quenched with ascorbic acid according the
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stoichiometric relationship of 2.5 parts of ascorbic acid to 1 part of free chlorine, and the
samples were then immediately analyzed by spectrophotometer and HPLC-UV-DAD. A
blank solution kept in the dark with 4-MBC and chlorine and suffering the same
temperature fluctuation was also analyzed.
In the second step (at the study along a higher reaction time), it was added
chlorine to the 4-MBC and OC reactions. Together with the photodegaration reactions
already described, there was also studied the degradation induced by both UV radiation
and chlorine. The reactions were carried out in glass vessels containing 100 mL of
deionized water. The deionized water samples were spiked with free chlorine to get the
initial concentration of 10 mg/L. After that, the pH of the aqueous solution was adjusted to
(7.0 ± 0.1) with 0.1 mol/L HCl and the resulting solution was then spiked with the stock
solutions of 4-MBC and OC in methanol to get the concentration of 1 mg/L (ratio UV-
filter:chlorine 1:10). These solutions were kept under direct natural radiation and their
temperature fluctuated according to the environmental temperature (between 21 and 26ºC
for 4-MBC and between 24 and 31ºC for OC) during the whole experiment, and also
under indirect natural UV radiation provided by a mercury lamp (PHILIPS, HPLR 400W)
emitting in the range of UV-B (280 to 315 nm) for OC [at constant temperature: (23.0 ±
2.0)ºC; the constant temperature was ensure by a glass vessel with double walls with
water circulating at room temperature]. The distance between de water surfaces into the
glass vessel and the lamp was 5.5 cm. An aliquot of the reactions mixtures was taken, the
excess of chlorine was quenched with ascorbic acid according the stoichiometric
relationship of 2.5 parts of ascorbic acid to 1 part of free chlorine, and the samples were
then immediately analyzed by spectrophotometer and HPLC-UV-DAD. A blank solution
with only the UV-filter was kept in the dark suffering the same temperature fluctuation was
also analyzed.
4.3.4. Chromatographic conditions
The reaction kinetics of the four UV-filters with chlorine and the degradation
induced by UV radiation were studied by HPLC-UV-DAD. The chromatographic system
was constituted by a isocratic pump (Hewlett-Packard 1100 Series, Boeblingen,
Germany), a manual sample injection valve with a 20 L loop (Rheodyne 7725i, Rohnert
Park, USA), a silica-based C18 reversed phase column (Hypersil GOLD Column 150 mm
 2.1 mm, particle size 5.0 m, pore diameter 175 Å, Thermo Scientific, USA) and a
photodiode array detector (UV 6000LP with a 50 mm LighPipe flow cell, Thermo Scientific,
San Jose, USA). The mobile phase was composed by acetonitrile and water (80%:20%,
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v/v) for BzS and 4-MBC and methanol and water (80%:20%, v/v) for PS and OC. Elutions
were performed at a constant flow rate (0.5 mL/min for BzS, 0.25 mL/min for PS, and 0.40
mL/min for 4-MBC and OC) under isocratic conditions. Absorbance was monitored at a
total scan mode from 210 to 600 nm. The system was controlled by Xcalibur version 1.4
SR.
The response of the HPLC-UV-DAD system was evaluated according to the ICH
guidelines (ICH, 2005) for each UV-filter. The linearity of the system was determined from
seven standard concentrations between 0.2 to 10 mg/L. Correlation coefficients (R) of the
resulting graphs were always higher than 0.999 and the quantification limits remained
under 0.1 mg/L.
4.4. Results and discussion
4.4.1. Study of the reaction kinetics of 4-MBC and OC in chlorinated water
The variation of the concentration of 4-MBC and OC with time, in the presence of
chlorine, was followed by HPLC-UV-DAD. Experiments were performed at pH 7.0, room
temperature and kept in the dark, at first using a ratio of UV-filter to chlorine of 1:10 and
then 5:10. 4-MBC was found not react with chlorine as we can see in Fig.4.3: normalized
values in the Y-axis correspond to the ratios between the responses for each sample from
chlorinated and nonchlorinated aliquots, multiplied by 100. As observed, the concentration
present in each aliquot sample doesn’t follow the decrease associated to the chlorine
reaction, as happens with BzS and PS.
Regarding OC, the variation of its concentration with time, in the presence of
chlorine, was followed by HPLC-UV-DAD. Experiments were performed at pH 7.0, room
temperature and kept in the dark, at first using a ratio of UV-filter to chlorine of 1:10. It was
found that OC did not react with chlorine did not occur in useful time (Fig.4.4). At the end
of the experiments (121 h) the transformation percentage was found to be 34.3%. Then,
the ratio UV-filter:chlorine was changed to 1:20 to improve the chance of the chlorine
reacts with OC (116 h). At the end of the experiments the transformation percentage was
found to be 94.5%. Then keeping the same proportion, the ratio UV-filter:chlorine was
changed to 0.5:10 and the variation of the concentration of OC with time in the presence
of chlorine was followed during 70h. However, 70 h is too much time to study the
chlorination reaction of UV-filters.
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The variation of the concentration of OC with time using a ratio of UV-filter to
chlorine of 0.25:10 was also assessed. The reaction was followed during 390 min and it
was observed only 20% of degradation.
Figure 4.3. C/Co (%) vs Reaction time for 4-MBC during reaction with chlorine at pH 7.0, room
temperature and in the dark. Concentrations are related to the corresponding control.
Figure 4.4. C/Co (%) vs Reaction time for OC during reaction with chlorine at pH 7.0, room
temperature and in the dark. Concentrations are related to the corresponding control.
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4.4.2. Study of the degradation induced by UV radiation of 4-MBC and OC
Once the reaction with chlorine was not observed and to increase the knowledge
about the reactions suffered by 4-MBC and OC in swimming pool water, the degradation
induced by UV radiation was studied. In a first stage, the photodegradation of 4-MBC and
OC was evaluated during 30 min.
Two solutions with 1 mg/L of 4-MBC, one of them covered by aluminium foil
(blank) were kept under artificial UV radiation provided by a mercury lamp. At each 10 min
a sample of each solution was taken and immediately analyzed in a UV/Vis
spectrophotometer and also by HPLC-UV-DAD. And it was observed that 4-MBC suffers a
quickly isomerization: the E-form changes to the Z-form (Fig.4.5). It would be expected
that the concentration of the E-form decreases along the reaction time and that the
concentration of the Z-form increases along the reaction time (Rodil et al., 2009) and this
behavior was observed (Fig.4.5). In the control reaction (the reaction kept in the dark) the
UV-filter did not suffers isomerization and its concentration was practically constant.
Figure 4.5. Time profiles of E-form and Z-form of 4-MBC (1 mg/L) during 30 min of artificial UV
radiation treatment. Concentrations are related to the initial concentration. Results obtained by
HPLC-UV-DAD.
Then, to improve the absorbance (0.04) obtained with 1 mg/L, it was tested a
solution with 10 mg/L of 4-MBC. The photodegradation of this solution was studied under
the same conditions of the previous one and the samples taken at 30, 40, 60 and 120 min
were analyzed by UV/Vis spectrophotometry. Again, a blank solution was covered by
aluminum foil and kept under the lamp. And, again, it was observed that the concentration
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of 4-MBC decreased along the reaction time (Fig.4.6). In the control reaction (the reaction
kept in the dark) its concentration was practically constant.
Figure 4.6. Time profiles of 4-MBC (10 mg/L) during 30 min of artificial UV radiation treatment.
Results obtained by UV/Vis spectrophotometry.
The photodegradation under natural UV radiation during 30 min it was also
evaluated. A solution with 1 mg/L of 4-MBC was kept under direct natural UV radiation
together to another solution. As happened under artificial UV radiation, 4-MBC suffered a
quickly isomerization between the two forms. And, in this case the concentration of the E-
form decreased along the reaction time while the concentration of 4-MBC suffered an
increasing (10 min) and then a decreasing (Fig.4.7). In the control reaction (the reaction
kept in the dark) the UV-filter did not suffers isomerization and its concentration was
practically constant.
So, it was added chlorine to evaluate if the degradation under UV radiation is
higher in presence of chlorine. The reaction was carried out in glass vessels containing
100 mL of deionized water. The deionized water samples were spiked with free chlorine to
get the initial concentration of 10 mg/L. After that, the pH of the aqueous solution was
adjusted to 7.0 ± 0.1 and the resulting solution was then spiked with 1 mg/L of 4-MBC.
This solution was kept under artificial UV radiation together to another solution with the
same ratio UV-filter:chlorine covered by aluminum foil. The reaction was performed during
30 min and at each 10 min a sample of each solution was taken, the excess of chlorine
was quenched with ascorbic acid according and immediately analyzed by
spectrophotometric and also by HPLC-UV-DAD. The results showed that 4-MBC suffers
quickly isomerization between E-form and Z-form. In presence of chlorine, the
concentration of the E-form decreased and the concentration of the Z-form suffered an
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increasing followed by a decreasing. Comparing to the results from the reaction without
chlorine, the concentration of both isomers was higher than their concentration in
presence of chlorine (Fig.4.8). In the control reaction (the reaction kept in the dark) the
UV-filter did not suffers isomerization and the concentration was constant during the 30
min of the reaction.
Figure 4.7. Time profiles of E-form and Z-form of 4-MBC of 4-MBC (1 mg/L) during 30 min of
natural UV radiation treatment. Concentrations are related to the initial concentration. Results
obtained by HPLC-UV-DAD.
Done this first approach, the photodegradation of 4-MBC was followed during a
higher reaction time. The solution with 1 mg/L of 4-MBC was kept under artificial UV
radiation provided by a mercury lamp. In this case, once 4-MBC did not showed
degradation in the solution covered by aluminum foil, no control solution was maintained
under the lamp covered by aluminum foil being that the control sample was taken at 0 min
at reaction after a stirring time to ensure a good dissolution. At each 30 min a sample was
taken and immediately analyzed by HPLC-UV-DAD. The isomerization of 4-MBC was only
observed after 60 min of the reaction and the results related to the concentration were
inconclusive. This experiment was performed with the temperature of the solution
fluctuating according the increasing of the temperature caused by the heat of the lamp.
So, to minimize the effect of the temperature in the measurements, the
temperature was maintained constant. A solution with 1 mg/L of 4-MBC was kept under
artificial UV radiation provided by a mercury lamp. In this case, once 4-MBC did not
showed degradation in the solution covered by aluminum foil, no control solution was
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maintained under the lamp covered by aluminum foil being that the control sample was
taken at 0 min at reaction after a stirring time to ensure a good dissolution. At each 30 min
a sample was taken and immediately analyzed by HPLC-UV-DAD. The results showed
that 4-MBC suffers a quickly isomerization. The concentration of the E-form decreased
along the reaction time and the concentration of the Z-form increased along the reaction
time (Fig.4.9).
Figure 4.8. Time profiles of 4-MBC (1 mg/L) alone and in presence of chlorine (10 mg/L) during 30
min of natural UV radiation treatment. Concentrations are related to the initial concentration.
Results obtained by HPLC-UV-DAD.
Figure 4.9. Time profiles of E-form and Z-form of 4-MBC of 4-MBC (1 mg/L) during 120 min of
artificial UV radiation treatment. Concentrations are related to the initial concentration. Results
obtained by HPLC-UV-DAD. Each point is the mean of two measurements.
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The photodegradation of 4-MBC under natural UV radiation was also followed
during a higher reaction time. A solution with 1 mg/L of 4-MBC was kept under direct
natural UV radiation during 360 min and samples were taken at each 60 min. The
samples were immediately analyzed by HPLC-UV-DAD. The results showed a quickly
isomerization of the filter between the E-form and the Z-form with the concentration of the
E-form decreasing and the concentration of the Z- form increasing slightly (Fig.4.10).
So, it was added chlorine to evaluate if the degradation under natural UV radiation
is higher in presence of chlorine and this reaction was followed during 360 min. The
reaction was carried out in glass vessels containing 100 mL of deionized water. The
deionized water samples were spiked with free chlorine to get the initial concentration of
10 mg/L. After that, the pH of the aqueous solution was adjusted to 7.0 ± 0.1 and the
resulting solution was then spiked with 1 mg/L of 4-MBC. This solution was kept under
natural UV radiation. In this case, and once 4-MBC did not showed degradation in the
solution covered by aluminum foil during the first approach, no control solution was
performed being that the control sample was taken at 0 min at reaction after a stirring time
to ensure a good dissolution (this control sample did not contained chlorine). At each 60
min a sample of the solution was taken, the excess of chlorine was quenched with
ascorbic acid according and immediately analyzed by spectrophotometric and also by
HPLC-UV-DAD. The results showed that 4-MBC suffers quickly isomerization. In
presence of chlorine, the concentration of the E-form decreased and the concentration of
the Z-form increased. Comparing to the results from the reaction without chlorine, the
concentration of the E-form was higher than its concentration in presence of chlorine,
while the concentration of the Z-form was similar with and without chlorine. (Fig.4.11).
Regarding the photodegradation of OC, it was performed a study very similar to
the 4-MBC one. At the 30 min assay, a solution with 0.5 mg/L of OC was kept under
artificial UV radiation provided by a mercury lamp. After 30 min of reaction a sample of the
solution was taken and immediately analyzed by spectrophotometric and also by HPLC-
UV-DAD. And it was observed that, contrary to 4-MBC, OC doesn’t suffers isomerization.
Done this first approach, the photodegradation of OC was followed during a higher
reaction time. A solution with 1 mg/L of OC was kept under artificial UV radiation provided
by a mercury lamp during 240 min and the temperature was maintained constant. The
control sample was taken at 0 min at reaction after a stirring time to ensure a good
dissolution. At each 60 min a sample was taken and immediately analyzed by HPLC-UV-
DAD. The results showed that the concentration of OC maintained relatively constant
(Fig.4.12).
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Figure 4.10. Time profiles of E-form and Z-form of 4-MBC (1 mg/L) during 360 min of
natural UV radiation treatment. Concentrations are related to the initial concentration. Results
obtained by HPLC-UV-DAD.
Figure 4.11. Time profiles of 4-MBC (1 mg/L) alone and in presence of chlorine (10 mg/L)
during 360 min of natural UV radiation treatment. Concentrations are related to the initial
concentration. Results obtained by HPLC-UV-DAD.
So, it was added chlorine to evaluate if the degradation under artificial UV radiation
is higher in presence of chlorine and this reaction was followed during 240 min. The
reaction was carried out in glass vessels containing 100 mL of deionized water. The
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deionized water samples were spiked with free chlorine to get the initial concentration of
10 mg/L. After that, the pH of the aqueous solution was adjusted to 7.0 ± 0.1 and the
resulting solution was then spiked with 1 mg/L of OC. This solution was kept under
artificial UV radiation. A control solution without chlorine was kept covered by aluminum
foil under artificial UV radiation. At each 60 min a sample of the reaction solution was
taken, the excess of chlorine was quenched with ascorbic acid according and immediately
analyzed also by HPLC-UV-DAD. Fig.4.12 compares the results obtained in this
experiment and the results obtained in the reaction with no chlorine kept under artificial
UV radiation.
Figure 4.12. Time profiles of OC (1 mg/L) alone and in presence of chlorine (10 mg/L) during 240
min of artificial UV radiation treatment. Concentrations are related to the initial concentration.
Results obtained by HPLC-UV-DAD.
The photodegradation of OC under natural UV radiation was also followed during
360 min. A solution with 1 mg/L of OC was kept under direct natural UV radiation during
360 min and samples were taken at each 60 min. The samples were immediately
analyzed by HPLC-UV-DAD. The results showed that its concentration decreased along
the reaction time (Fig.4.13).
So, it was added chlorine to evaluate if the degradation under natural UV radiation
is higher in presence of chlorine and this reaction was followed during 360 min. The
reaction was carried out in glass vessels containing 100 mL of deionized water. The
deionized water samples were spiked with free chlorine to get the initial concentration of
10 mg/L. After that, the pH of the aqueous solution was adjusted to 7.0 ± 0.1 and the
resulting solution was then spiked with 1 mg/L of OC. This solution was kept under natural
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UV radiation and at each 60 min a sample of the solution was taken, the excess of
chlorine was quenched with ascorbic acid according and immediately analyzed by HPLC-
UV-DAD. Fig.4.13 compares the results obtained in this experiment and the results
obtained in the reaction with no chlorine kept under artificial UV radiation.
Figure 4.13. Time profiles of OC (1 mg/L) alone and in presence of chlorine (10 mg/L) during 360
min of natural UV radiation treatment. Concentrations are related to the initial concentration.
Results obtained by HPLC-UV-DAD.
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5. Toxicological assays
5.1. Introduction
PPCPs have been found in several water supplies, waste waters and natural
aquatic environmental around the world (Gago-Ferrero et al., 2013; Subedi et al., 2012;
Sui et al., 2011; Westerhoff et al., 2005). They were already detected in several animal as
happened with some UV-filters found in tissue liver of Franciscana dolphin (Pontoporia
blaivinelli) from Brazilian coast area (Gago-Ferrero et al., 2013), and antihistamines,
antidepressants and musks found in fishes from German Environment Species Bank
(Subedi et al., 2012).
UV-filters have high lipophilicity (mostly with log Kow 4–8) whereby they have been
shown to accumulate in the food chain and in human milk fat. However, at present, there
is a scarcity of data on environmental concentrations of UV-filters (Díaz-Cruz et al., 2008;
Gago-Ferrero et al., 2013). Moreover, concentrations reported fluctuate significantly as a
function of sample location, size of the system under study (e.g., lakes and swimming
pools), frequency and type of recreational activities, season of the year and hour of the
day. Still, maximum concentrations reported have corresponded to mid-day on warm
summer days, as expected (Díaz-Cruz et al., 2008). In natural waters BP3 is the most
frequently detected UV-filter with its concentrations ranging from 2 to 125 ng/L. However,
is 4-MBC the UV-filter that is detected in the highest concentrations: up to 82 ng/L (Díaz-
Cruz and Barceló, 2009)
Lakes river waters are the less contaminated aquatic environments. Nevertheless
there are several studies describing concentrations of UV-filters in fish from rivers and
lakes contaminated with wastewaters: 1.8 mg/Kg lipid (4-MBC), 2 mg/Kg lipid and 0.5
mg/Kg lipid (others UV-filters) (Díaz-Cruz and Barceló, 2009). It can be said that fishes
are the primary organisms to monitor the presence of lipophilic compounds such as UV-
filters (Díaz-Cruz and Barceló, 2009). OC, which also has a high lipophilicity (Kow 6.88),
was also already detected in tissues liver of dolphins (Pontoporia blainvillei) with
concentrations in the range 89−782 ng/g lw and there is evidence that maternal transfer
may occur through placenta and likely also through breast milk (Subedi et al., 2012).
Swimming pool water had the higher levels of UV-filters. 4-MBC and BP3 were
already detected in concentrations of 330 ng/L and 400 ng/L respectively (Díaz-Cruz and
Barceló, 2009). In swimming pools the chlorine used in disinfection may react with the UV-
filters as reacts with natural organic matter of water, yielding DBPs such as chloroform
and other trihalomethanes, nitrosamines or haloacetic acids which have toxic effects like
carcinogenic effects in animals and human beings (Hrudey, 2009). Now, it is mandatory to
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assess the toxicity of DBPs formed from PPCPs chlorination. The knowledge of this
subject is still poor but there are already a few papers published in order to study the
toxicity of some of these compounds. Bladder cancer has been associated with exposure
to chlorination byproducts in drinking water, and experimental evidence suggests that
exposure also occurs through inhalation and dermal absorption during swimming in pools
because certain DBPs have high volatility and dermal permeability. Villanueva et al.
(Villanueva et al., 2007) observed that subjects who had ever swum in a pool showed an
increased risk of bladder cancer compared with those who had never swum in pools and
former and current smokers present an excess risk of bladder cancer. This study also
revealed a duration-response relation for cumulative time spent in swimming pools. To
evaluate the genotoxicity of swimming pool water in swimmers, Kogevinas and co-workers
(Kogevinas et al., 2010) examined some biomarkers of genotoxicity in an experimental
study in which adults swam for 40 min in a chlorinated, indoor swimming pool, comparing
the biomarker results with the concentrations of four THMs (bromoform,
bromodichloromethane, chloroform and chlorodibromomethane) in exhaled breath. It was
observed increases in two biomarkers of genotoxicity (micronuclei in in peripheral blood
lymphocytes and urinary mutagenicity). Although only brominated THMs showed
genotoxicity, all four are carcinogenic in rodents.
UV-filters also showed hormonal activity in vitro and in vivo inducing vitellogenin,
causing alterations in gonads, decreasing fertility and leading to the feminization in sex
characteristics of male fish (Díaz-Cruz and Barceló, 2009). These effects are associated
mainly with the exposure to benzophenones and camphor-related UV-filters at
concentrations higher than those reported in the environment. However, the rapid
accumulation of these compounds in the environment and the potential for mixture effects
warrant further research to assess the fate and the effects of the UV-filters in aquatic
ecosystems (Díaz-Cruz and Barceló, 2009). 4-MBC also showed effects in
hypothalamuspituitary–gonadal system in male rats altering gonadal weight and steroid
hormone production (Brausch and Rand, 2011).
BP3 was also found as an allergen (Berne and Ros, 1998) as well as OC which
appears to be a strong allergen causing contact dermatitis in children and photoallergic
contact in adults (Avenel-Audran et al., 2014)
Zebrafish (Danio rerio) can be used as an animal model to test the accumulation
and the adverse effects of UV-filters. Blüthgen et al. (Blüthgen et al., 2014) exposed
males of zebrafish to OC, which as a high tendency to bioaccumulation due to its high
lipophilicity and low biodegradability. It was observed no effect on survival. Calculated
bioconcentration factors [BCF = concentration in fish (ng/g body weight) / concentration in
water (µg/L] ranged between 41 and 136. They also verified that OC affects transcription
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of genes related to some biological pathways of G0 process in the brain (development
process, anatomical structure development, system development, multicellular organismal
processes end development, response to steroid hormone stimulus, anatomical structure
morphogenesis, positive regulation of cellular process, organ development and cellular
component organization) and in the liver (xenobiotic metabolic processes, cellular
response to xenobiotic stimulus, urea cycle and metabolic processes, nitrogen cycle
metabolic processes, lung and respiratory tube development ad response to vitamin B2).
Transcription of genes related to pathways responsible for fat cell differentiation,
regulation of the metabolism of thyroide hormones (triiodothyronine and thyroxine) and
thyroxine signaling, polyamine metabolism (polyamines are important to DNA replication
and consequently to cell growth), inflammatory mediators signaling, cytoskeleton
intermediate filaments, and signal transduction of the androgen nuclear receptor pathway
and others are also affected by the exposure to OC.
The products from photodegradation of UV-filters may also cause some toxic
concerns (Butt and Christensen, 2000). Photodegradation of BDM and EHMC is already
known and the toxicity of their photoproducts was already studied using cells of mouse
lymphoma by Butt and Christensen (Butt and Christensen, 2000). It was observed that the
parental compound of EHMC caused cell death as well as the parental compound of
BDM, although this last one is less toxic since it was necessary a higher concentration to
cause cell death. Regarding photoproducts, in this study only EHMC showed products
resulting from its photodegradation which were more toxic than the parental compound.
BDM is a commonly used UV-filter present in many sunscreens absorbing in UVA
region (Shaath, 2010). The chlorination reaction of BDM was already assessed by Santos
et al. (Santos et al., 2013) and its DBPs were already identified as mono- and dichloro-
substituted compounds resulting from substitution of the hydrogen atoms in the benzene
rings by one or two chlorine atoms. So, the aim of this study was given a first approach on
the assessment of the toxicity of the UV-filter BDM and its DBPs.
5.2. Materials and Methods
5.2.1. Reagents
BDM, CAS Registry No. [70356-09-1], 98%, (molecular formula C20H22O3) was
purchased from Merck. A commercial sodium hypochlorite solution with a chlorine content
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of <5% (28 mg/L of free chlorine) was used to obtain DBPs from BDM. This solution was
stored at 4ºC and its free chlorine content was periodically measured by a small compact
photometer for chlorine (HANNA Checker Mini Hi 701 series). Stock solutions of the BDM
were prepared with methanol from Merck. Deionized water (conductivity < 0.1 S cm-1)
was used in all experiments. Ascorbic acid (99.7%) used to quench the free chlorine was
obtained from Merck. Sodium chlorine used to enrich the solutions was obtained from
José M. Valz Pereira, LDA., Lisboa, Portugal. The pH of the solutions was adjusted to a
pre-determined value with HCl solutions 0.1 mol/L. Eluents for chromatographic analysis
(methanol) were liquid chromatographic grade and were bought from Merck. A Nikon
Eclipse TE300 microscope and a VWR stereo microscope SZT series were used to the
daily readings.
5.2.2. Zebrafish and egg production
Zebrafish (Danio rerio) larvae were acutely exposed to several concentrations of
BDM and corresponding DBPs solution resulting from chlorination reaction. The effect of
these compounds regarding mortality and anatomic abnormalities was assessed.
5.2.2.1. Parental generation
Adult wild-type zebrafish (Danio rerio) were obtained from Singapore and were
used as breeding stocks. Zebrafish specimens were kept in 250 L aquaria with
dechlorinated water in a recirculation system with mechanical filters at a temperature
water of (28 ± 1)ºC on a photoperiod 14:10 h (light:dark). The fishes were fed ad libitum
twice a day with a commercial fish diet Tetramin (Tetra, Melle, Germany). The aquaria
contained 12-14 females and 6-7 males.
5.2.2.2. Egg production of parental generation
In the afternoon before breeding, two groups of zebrafish couples were
independently housed in cages attached to the aquaria with water circulating between the
aquaria and the cages (one couple per aquarium). The photoperiod conditions were also
the same and in this day the fishes were fed ad libitum four times. At the morning of the
following day, breeding fish were removed 1.5 h after the beginning of the light period and
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the eggs were collected and cleaned. This point was recorded as 0 h post fertilization
(hpf). Fertilized eggs were allocated in petri dish with autoclaved water and methylene
blue kept at (28 ± 1)ºC on a photoperiod 14:10 h (light:dark).
5.2.3. Exposure (study design)
Three days post fertilization (dpf) the larvae were collected and exposed to the
solutions. Four assays were performed separately and the exposure conditions were
different.
5.2.3.1. First assay
Larvae were randomly distributed in 6-well plate (5 larvae per exposure condition;
400 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h (light:dark)
throughout the assay. Larvae were continuously exposed to the exposure conditions from
3 dpf to 5 dpf. In this assay, BDM and its DBPs were applied at the concentration of 1
mg/L. Stock solutions of BDM in methanol (about 100 mg/L) were first prepared. The
tested solutions were prepared in deionized water spiked with the stock solution. The
DBPs were obtained by the reaction between BDM and free chlorine (ratio UV-
filter:chlorine 1:10 mg/L). This reaction was performed at the beginning of each day
whereby the DBPs solutions contained some chlorine. The concentration of the DBPs was
determined by HPLC-UV-DAD comparing the pikes corresponding to the same
concentration of the parental BDM. A solution of deionized water spiked with free chlorine
to get the concentration of 10 mg/L was bubbled with air to remove the chlorine was used
as control. At the beginning of the assay, the chlorine concentration in the control solution
was 0.04 ppm. All the solutions were kept in the dark till they were applied. Dead larvae
were removed during the daily readings and two out of three of each well content were
renewed with freshly prepared exposure solution. Potential anatomic abnormalities were
also recorded.
5.2.3.2. Second assay
Larvae were randomly distributed in 24-well plate (5 larvae per well, 15 larvae per
exposure condition; 500 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h
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(light:dark) throughout the assay. Larvae were continuously exposed to the exposure
conditions from 3 dpf to 6 dpf. In this assay, BDM and its DBPs were applied at the
concentration of 1 mg/L. Stock solutions of BDM in methanol (about 100 mg/L) were first
prepared. The tested solutions were prepared in deionized water enriched with sodium
chloride (NaCl) to get the concentration of 5.03 mM (CSH protocols, 2011) and spiked
with the stock solution. The DBPs were obtained by the reaction between BDM and free
chlorine (ratio UV-filter:chlorine 1:10 mg/L). This reaction was performed 3 days before
the application, with the purpose to get the concentration of free chlorine of 0.30 mg/L.
The concentration of the DBPs was determined by HPLC-UV-DAD comparing the pikes
corresponding to the same concentration of the parental BDM. A solution of deionized
water spiked with free chlorine to get the concentration of 0.3 mg/L, a solution of
deionized water spiked with free chlorine at the concentration of 0.3 mg/L enriched with
NaCl (to get the concentration of 5.03 mM) and a solution of deionized water with 5.03
mM of NaCl were used as control. Autoclaved water was also used as control. All the
solutions were kept in the dark till they were applied. Dead larvae were removed during
the daily readings and two out of three of each well content were renewed with freshly
prepared exposure solution. Potential anatomic abnormalities were also recorded.
5.2.3.3. Third assay
Larvae were randomly distributed in 24-well plate (15 larvae per well, 30 larvae per
exposure condition; 500 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h
(light:dark) throughout the assay. Larvae were continuously exposed to the exposure
conditions from 3 dpf to 7 dpf. In this assay, BDM and its DBPs were applied at the
concentration of 0.1 mg/L. Stock solutions of BDM in methanol (about 100 mg/L) were first
prepared. The tested solutions were prepared in deionized water enriched with sodium
chloride (NaCl) to get the concentration of 5.03 mM (CSH protocols, 2011) and spiked
with the stock solution. The DBPs were obtained by the reaction between BDM and free
chlorine (ratio UV-filter:chlorine 1:10 mg/L). After 30 min of the beginning of this reaction
(this reaction time assure that BDM is totally transformed by chlorine) the solution was
concentrated by liquid-liquid extraction with ethyl acetate (three extractions with 20 mL
each). After this procedure the organic solvent was evaporated and 1 mL of methanol was
added to the final residue. The concentration of the DBPs was determined by HPLC-UV-
DAD comparing the pikes corresponding to the same concentration of the parental BDM.
These samples were maintained in dark until they were used and dilute in deionized water
enriched with NaCl. Although this procedure assured that almost all of the free chlorine
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was eliminated, free chlorine content of the final solutions of DBPs was assessed and,
when it was necessary, it was added ascorbic acid to neutralize free chlorine. So, a
solution with ascorbic acid at the concentration of 0.15 mg/L (the concentration requested
to neutralize the higher level of free chlorine that was found) was used as control. A
solution of deionized water with 5.03 mM of NaCl and autoclaved water were also used as
controls. All the solutions were kept in the dark till they were applied. Dead larvae were
removed during the daily readings and two out of three of each well content was renewed
with freshly prepared exposure solution. Potential anatomic abnormalities were also
recorded.
5.2.3.4. Fourth assay
Larvae were randomly distributed in 24-well plate (5 larvae per well, 15 larvae per
exposure condition; 500 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h
(light:dark) throughout the assay. Larvae were continuously exposed to the exposure
conditions from 3 dpf to 7 dpf. In this assay, BDM and its DBPs were applied at the
concentration of 0.1, 1 and 10 µg/L. Stock solutions of BDM in methanol (about 100 mg/L)
were first prepared. The tested solutions were prepared in deionized water enriched with
sodium chloride (NaCl) to get the concentration of 5.03 mM (CSH protocols, 2011) and
spiked with the stock solution. The DBPs were obtained by the reaction between BDM
and free chlorine (ratio UV-filter:chlorine 1:10 mg/L). After 30 min of the beginning of this
reaction (this reaction time assure that BDM is totally transformed by chlorine) the solution
was concentrated by liquid-liquid extraction with ethyl acetate (three extractions with 20
mL each). After this procedure the organic solvent was evaporated and 1 mL of methanol
was added to the final residue. The concentration of the DBPs was determined by HPLC-
UV-DAD comparing the pikes corresponding to the same concentration of the parental
BDM. These samples were maintained at -4ºC and in dark until they were used and dilute
in deionized water enriched with NaCl. Although this procedure assured that almost all of
the free chlorine was eliminated, free chlorine content of the final solutions of DBPs was
assessed and, when it was necessary, it was added ascorbic acid to neutralize free
chlorine. So, a solution with ascorbic acid at the concentration of 0.15 mg/L (the
concentration requested to neutralize the higher level of free chlorine that was found) was
used as control. A solution of deionized water with 5.03 mM of NaCl and autoclaved water
were also used as controls. All the solutions were kept in the dark till they were applied.
Dead larvae were removed during the daily readings and two out of three of each well
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content were renewed with freshly prepared exposure solution. Potential anatomic
abnormalities were also recorded.
5.2.3.5. Touch response test
At the end of the third assay, with the larvae with 7 dpf, it was performed a touch
response test. At 96 hpf the larva is freely swimming and is able to change swimming
directions spontaneously and to direct its swimming towards targets. Mechanical stimuli
near the head of the larva induce a fast escape response (Genes controlling and
mediating locomotion behavior of the zebrafish embryo and larva). Tests like this on allow
the identification of changes in sensory and locomotor functions (The Developmental
Neurotoxicity of Fipronil: Notochord Degeneration and Locomotor Defects in Zebrafish
Embryos and Larvae). After the last reading of the third assay, each larva was displaced
to a petri dish with autoclaved water. After a little period of habituation and stabilization
(around 2 min), it was applied a short mechanical stimulus with a pipette tip in its head
and tail. It was recorded the response of the larvae regarding escaping or don’t.
5.2.4. Statistics
All the statistical tests were performed in Microsoft Excel 2013.
5.3. Results and discussion
Zebrafish (Danio rerio) was used to assess the toxicity caused by another UV-filter
already studied: BDM (Santos et al., 2013). Larvae of Zebrafish were acutely exposed to
several concentrations of BDM and corresponding DBPs solution resulting from
chlorination reaction. The effect of these compounds regarding mortality and anatomic
abnormalities was assessed.
5.3.1. First assay
Larvae were randomly distributed in 6-well plate (5 larvae per exposure condition;
400 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h (light:dark)
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throughout the assay. Larvae were continuously exposed to 1 mg/L of BDM and 1 mg/L of
its DBPs from 3 dpf to 5 dpf. In this assay, the control solution was deionized water spiked
with free chlorine to get the concentration of 10 mg/L and bubbled with air to remove the
chlorine. At the beginning of this assay, the chlorine level was 0.04 ppm.
The DBPs were obtained by the reaction between BDM and free chlorine (ratio
UV-filter:chlorine 1:10 mg/L). This reaction was performed at the beginning of each day
whereby the DBPs solutions contained some chlorine. Before all these toxicological tests,
the behavior of the DBPs was followed by HPLC-MS and the pikes obtained in the
chromatogram were consistent to the pikes obtained by Santos et al. (Santos et al., 2013).
After 30 min of reaction BDM is completely transformed and the concentration of its DBPs
reaches its maximum. After that, it was observed that the concentration of the DBPs
decreases as the time goes by, as well as the concentration of free chlorine. However, at
the beginning of this assay, the concentration of chlorine was too high that all the larvae
exposed to the solution of DBPs died after the first day of the assay. All the larvae
exposed to BDM showed abnormalities and the larvae in the control also showed mortality
and some abnormalities
So, this first assay was finished after the first day of exposure and the solutions of
the exposure conditions were improved to others assays.
5.3.2. Second assay
Larvae were randomly distributed in 24-well plate (5 larvae per well, 15 larvae per
exposure condition; 500 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h
(light:dark) throughout the assay. Larvae were continuously exposed to 1 mg/L of BDM
and 1 mg/L of its DBPs from 3 dpf to 6 dpf. In this assay, two different solutions of DBPs
were tested. In the first one, similar to the first assay, the DBPs were obtained by the
reaction between BDM and free chlorine (ratio UV-filter:chlorine 1:10 mg/L) and this
reaction was performed at the beginning of each day. So, these DBPs solutions contained
high levels of free chlorine. In the second one, and since the behavior of the DBPs and
free chlorine concentration along the reaction time was followed, the DBPs were obtained
also by the reaction between BDM and free chlorine (ratio UV-filter:chlorine 1:10 mg/L) but
it was applied to the larvae only after 3 days, when the concentration of free chlorine is
lower (0.30 ppm).
In the first assay, the higher mortality observed may be due to the fact that the
tested solutions did not contain any nutrients necessary to a correct development of the
larvae since the tested solutions were prepared with deionized water. So, to overcome
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this question, at the beginning of the assay the tested solutions were applied with the
double of the concentration diluted in the zebrafish medium (50:50 of tested
solution:zebrafish medium). In the next days, the tested solutions were enriched with NaCl
to provide the nutritional requirement of the larvae. So, the control solutions were
autoclaved water (which was the zebrafish medium), deionized water with free chlorine
ate 0.30 ppm, deionized water with NaCl and deionized water with free chlorine (0.30
ppm) enriched with NaCl.
In the end of this assay (larvae at 6 dpf) the larvae exposed to BDM showed
neither mortality (Fig.5.1) nor abnormalities (Fig.5.2). However, the larvae exposed to the
BDM solution with 0.30 ppm of chlorine showed some abnormalities (Fig.5.2) at the end of
the assay. These abnormalities consisted in skeletal defects (curved spine) but these
results don’t have statistical significance (p>0.05). All the larvae exposed to BDM solution
with 10 mg/L of chlorine died after the first day of the assay.
Since the lack of nutrients may be the reason to the high mortality during the first
assay, here it was compared two control solutions: autoclaved water and deionized water
enriched with NaCl. No mortality was observed in these two tested conditions (Fig.5.1)
however, at the end of this assay (larvae at 6 dpf), the larvae in autoclaved water showed
skeletal defects (Fig.5.2) which don’t have statistical significance (p>0.05).
To assess the effect the 0.30 ppm of free chlorine, it was compared two others
control solutions: deionized water with free chlorine ate 0.30 ppm and deionized water
with free chlorine (0.30 ppm) enriched with NaCl. No mortality was recorded in any of
these two tested conditions (Fig.5.1). However, at the end of this assay (larvae at 6 dpf),
the larvae exposed to the solution with free chlorine enriched with NaCl showed skeletal
defects (Fig.5.2) which don’t have statistical significance (p>0.05). Still, at the third day of
the assay (larvae at 5 dpf) the number of larvae exposed to the solution with free chlorine
enriched with NaCl with skeletal defects was higher than the number recorded at the end
of the assay (larvae at 6 dpf) (Fig.5.3), whereby the larvae showed some kind of
regeneration. Similar to the previous result, these effects don’t have statistical significance
(p>0.05).
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Figure 5.1. Percentage of mortality at the end of the assay (6 dpf) for the four control solutions
(autoclaved water, deionized water enriched with NaCl, deionized water spiked with chlorine to get
0.30 ppm of free chlorine, and deionized water spiked with chlorine to get 0.30 ppm of free chlorine
enriched with NaCl), 1 mg/L of BDM and 1 mg/L of DBPs with 0.30 ppm of chlorine.
Figure 5.2. Percentage of abnormalities at the end of the assay (6 dpf) for the four control solutions
(autoclaved water, deionized water enriched with NaCl, deionized water spiked with chlorine to get
0.30 ppm of free chlorine, and deionized water spiked with chlorine to get 0.30 ppm of free chlorine
enriched with NaCl), 1 mg/L of BDM and 1 mg/L of DBPs with 0.30 ppm of chlorine.
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Figure 5.3. Percentage of abnormalities along the assay for the four control solutions (autoclaved
water, deionized water enriched with NaCl, deionized water spiked with chlorine to get 0.30 ppm of
free chlorine, and deionized water spiked with chlorine to get 0.30 ppm of free chlorine enriched
with NaCl), 1 mg/L of BDM and 1 mg/L of DBPs with 0.30 ppm of chlorine.
So, due to the lack of statistical relevance of this assay, it cannot be concluded if
the parental compound on larvae as different effects than the ones caused by its DBPs.
5.3.3. Third assay
Larvae were randomly distributed in 24-well plate (15 larvae per well, 30 larvae per
exposure condition; 500 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h
(light:dark) throughout the assay. Larvae were continuously exposed to 0.1 mg/L of BDM
and 0.1 mg/L of its DBPs from 3 dpf to 7 dpf. In this assay, two different solutions of DBPs
were tested. In the first one, similar to the others assay, the DBPs were obtained by the
reaction between BDM and free chlorine (ratio UV-filter:chlorine 1:10 mg/L). In this case,
this reaction was performed at 12h before the each day of the assay. After 30 min of
reaction (this reaction time assures that BDM is totally transformed by chlorine) the
solution was concentrated by liquid-liquid extraction with ethyl acetate and the organic
solvent was evaporated. These procedure ensured that the chlorine present in the
solutions was removed, eliminating this variable in the assay. Nevertheless, the chlorine
level of the solution of DBPs was controlled as well as the pH (pH near 7). Whenever
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there was free chlorine in the solutions, it was added ascorbic acid to neutralize it. The
behavior of the DBPs in these solutions was followed by HPLC-UV-DAD and it was
observed that the concentration of the DBPs decreased along the time, whereby the
solutions of DBPs were prepared daily.
To ensure the nutritional requirement of the larvae, it was maintained the same
procedure of the second assay: at the beginning of the assay the tested solutions were
applied with the double of the concentration diluted in the zebrafish medium (50:50 of
tested solution:zebrafish medium). In the next days, the tested solutions were enriched
with NaCl to provide the nutritional requirement of the larvae. So, the control solutions
were autoclaved water (which was the zebrafish medium), and deionized enriched with
NaCl. Once there was the risk that chlorine was not completely removed during the
extraction process, a solution of deionized water and ascorbic acid (0.15 ppm, the
minimum value of ascorbic acid necessary to neutralize the free chlorine; this value was
obtained during preliminary experiments) was also applied as control.
In the end of this assay (larvae at 7 dpf) the larvae exposed to BDM showed no
mortality but it was recorded some skeletal defects (curved spine): 13.33% of the larvae
exposed to this exposure condition (Fig.5.4). However, comparing to the control
(deionized water enriched with NaCl) these results don’t have statistical relevance
(p>0.05). Similar to the previous assay, at the fourth day of the assay (larvae at 6 dpf) the
percentage of larvae exposed to the BDM with skeletal defects (60%) was higher than the
percentage recorded at the end of the assay (larvae at 7 dpf) (Fig.5.5), whereby the larvae
showed some kind of regeneration. This result was statistical relevant (p<0.05).
Regarding the larvae exposed to the DBPs, it was observed no mortality but it was
observed skeletal defects (curved spine): 3.33 % of the larvae at the end of the second
day of the assay (larvae at 4 dpf) but this result was not statistical relevant (p>0.05)
comparing to the control (deionized water with ascorbic acid enriched with NaCl). In the
rest of the assay, the larvae apparently recovered from these defects (Fig.5.5).
In the controls, it was observed a larva with a hemorrhage in the autoclaved water
since the beginning of the assay. This larva survived until the end. In deionized water
enriched with NaCl, 3.33 % of the larvae showed skeletal defects (curved spine) since 5
dpf and no effect caused by ascorbic acid in the corresponding control was detected.
These differences between these two controls are not statistical relevant (p>0.05)
(Fig.5.4).
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Figure 5.4. Percentage of abnormalities at the end of the assay (7 dpf) for the three control
solutions (autoclaved water, deionized water enriched with NaCl, ascorbic acid enriched with
NaCl), 0.1 mg/L of BDM and 0.1 mg/L of DBPs.
Figure 5.5. Percentage of abnormalities along the assay for the three control solutions (autoclaved
water, deionized water enriched with NaCl, ascorbic acid enriched with NaCl), 0.1 mg/L of BDM
and 0.1 mg/L of DBPs.
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So, from this assay, it can be concluded that BDM causes abnormalities to the
larvae of zebrafish at the concentration of 0.1 mg/L but its DBPs at the same
concentration have no effect on the larvae.
5.3.4. Fourth assay
Larvae were randomly distributed in 24-well plate (5 larvae per well, 15 larvae per
exposure condition; 500 µL solution/well) and kept at (28 ± 1)ºC on a photoperiod 14:10 h
(light:dark) throughout the assay. Larvae were continuously exposed to 0.1 µg/L, 1 µg/L
and 10 µg/L of BDM and 0.1 µg/L, 1 µg/L and 10 µg/L of its DBPs from 3 dpf to 7 dpf. In
this assay, two different solutions of DBPs were tested. In the first one, similar to the
others assay, the DBPs were obtained by the reaction between BDM and free chlorine
(ratio UV-filter:chlorine 1:10 mg/L). In this case, this reaction was performed several days
before the each day of the assay and the concentrated samples were kept at -4ºC. After
30 min of reaction (this reaction time assures that BDM is totally transformed by chlorine)
the solution was concentrated by liquid-liquid extraction with ethyl acetate and the organic
solvent was evaporated. These procedure ensured that the chlorine present in the
solutions was removed, eliminating this variable in the assay. Nevertheless, the chlorine
level of the solution of DBPs was controlled as well as the pH (pH near 7). Whenever
there was free chlorine in the solutions, it was added ascorbic acid to neutralize it. Still, in
this assay it was not necessary add ascorbic acid to the DBPs solutions. The behavior of
the DBPs kept in ice was followed by HPLC-UV-DAD and it was observed that the
concentration of the DBPs decreased along the time but not so fast as it happens at the
temperature room, whereby the solutions of DBPs were prepared several days before the
beginning of the assay. However, every day of the assay, new solutions of DBPs were
prepared to minimize the decrease of its concentration.
To ensure the nutritional requirement of the larvae, it was maintained the same
procedure of the second assay: at the beginning of the assay the tested solutions were
applied with the double of the concentration diluted in the zebrafish medium (50:50 of
tested solution:zebrafish medium). In the next days, the tested solutions were enriched
with NaCl to provide the nutritional requirement of the larvae. So, the control solutions
were autoclaved water (which was the zebrafish medium), and deionized enriched with
NaCl. Once there was the risk that chlorine was not completely removed during the
extraction process, a solution of deionized water and ascorbic acid (0.15 ppm, the
minimum value of ascorbic acid necessary to neutralize the free chlorine. This value was
obtained during preliminary experiments) was also applied as control.
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Figure 5.6. Percentage of mortality at the end of the assay (7 dpf) for the three control solutions
(autoclaved water, deionized water enriched with NaCl, ascorbic acid enriched with NaCl), 0.1 µg
/L, 1 µg/L and 10 µg/L of BDM, and  0.1 µg /L, 1 µg/L and 10 µg/L of DBPs.
In the end of this assay (larvae at 7 dpf) the larvae exposed to 0.1 µg/L of BDM
showed 93.3 % of mortality (Fig.5.6). Comparing to the control (deionized water enriched
with NaCl) these results have statistical relevance (p<0.05). 6.67 % of these larvae
showed an abnormal position swimming with the side facing down (Fig.5.7). However,
comparing to the control (deionized water enriched with NaCl) these results don’t have
statistical relevance (p>0.05). The larvae exposed to 1 µg/L and to 10 µg/L of BDM
showed no mortality and none abnormalities.
In the end of this assay (larvae at 7 dpf) the larvae of the three experimental
conditions (0.1 µg/L, 1 µg/L and 10 µg/L of DBPs) showed 100 % of mortality (Fig.5.6) and
these results have statistical relevance (p<0.05). It was observed that the larvae exposed
to 10 µg/L died at the second day of the assay (4 dpf) (Fig.5.8). At this point, the larvae
exposed to 1 µg/L of DBPs have already 80 % of mortality (p<0.05) and the larvae
exposed to 0.1 µg/L of DBPs don’t have mortality although they showed 33.3 % of some
abnormalities: 26.6 % of heart failure, and 6.6 % of the larvae showed an abnormal
position swimming with the side facing down. However, comparing to the control
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(deionized water enriched with NaCl) these results don’t have statistical relevance
(p>0.05). At the third day of the assay (5 dpf), the conditions of the larvae exposed to 1
µg/L of DBPs didn’t suffer any change, while the mortality of the larvae exposed to 0.1
µg/L increased to 33.3 % and 26.6 % showed an abnormal position swimming with the
side facing down. The dead larvae were those were with heart failure at 4 dpf. However,
these results don’t have statistical relevance (p>0.05) comparing to the control (deionized
water enriched with NaCl). At the fourth day of the assay (6 dpf), the mortality of the
larvae exposed to 1 µg/L increased to 80 % (p<0.05) and it was observed none
abnormalities. The mortality of the larvae exposed to 0.1 µg/L was the same and the
percentage of abnormalities increased to 33.3 % (p>0.05).
Figure 5.7. Percentage of abnormalities at the end of the assay (7 dpf) for the three control
solutions (autoclaved water, deionized water enriched with NaCl, ascorbic acid enriched with
NaCl), 0.1 µg /L, 1 µg/L and 10 µg/L of BDM, and  0.1 µg /L, 1 µg/L and 10 µg/L of DBPs.
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Figure 5.8. Percentage of mortality along the assay for the three control solutions (autoclaved
water, deionized water enriched with NaCl, ascorbic acid enriched with NaCl), 0.1 µg /L, 1 µg/L and
10 µg/L of BDM, and  0.1 µg /L, 1 µg/L and 10 µg/L of DBPs.
Comparing the effects caused by BDM and the effects caused by the DBPs it was
observed significant differences (p<0.05) between the results at the end of the assay. And
from this assay, it can be concluded that BDM causes mortality on the larvae of zebrafish
at the concentration of 0.1 µg/L, at the concentration of 10 µg/L DMB has no effect on the
larvae of zebrafish, and its DBPs causes mortality at the three tested concentrations: 0.1
µg/L, 1 µg/L and 10 µg/L.
5.3.4. Touch response test
At the end of the third assay, with the larvae with 7 dpf, it was performed a touch
response test.
Embryos of zebrafish exhibit the first movements at 17 hpf. These movements
consist of alternating side-to-side contractions of the tail that curls slowly whereby the tip
of the tail reaches de head. At 24 hpf the larvae react already to mechanical stimuli on the
head or the tail by contracting the tail in a faster way than they already do at 17 hpf. At 26
hpf the larvae of zebrafish acquire the ability to swim when it is applied a mechanical
stimulus (Saint-Amant and Drapeau, 1998). At 96 hpf the larva is freely swimming and is
able to change swimming directions spontaneously and to direct its swimming towards
targets. Mechanical stimuli near the head of the larva induce a fast escape response
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(Granato et al., 1996; Saint-Amant and Drapeau, 1998). Tests like this on allow the
identification of changes in sensory and locomotor functions (Stehr et al., 2006).
After the last reading of the third assay, each larva was displaced to a petri dish
with autoclaved water. After a little period of habituation and stabilization (around 2 min), it
was applied a short mechanical stimulus with a pipette tip in its head and tail. It was
recorded the response of the larvae regarding escaping or don’t (Table 5.1).
Regarding the responses from stimuli applied in the head, the differences obtained
between the two controls (deionized water enriched with NaCl and deionized water with
ascorbic acid enriched with NaCl) were not statistical significant (p<0.05). 33.3 % (p<0.05)
of the larvae exposed to the BDM had a positive response (the larvae swam away from
the stimulus). The larvae exposed to the DBPs showed 50 % (p<0.05) of positive
response.
Regarding the responses from stimuli applied in the tail, 76.6 % of the larvae
exposed to the BDM had a positive response (the larvae swam away from the stimulus)
and the larvae exposed to the DBPs showed 66.6 % of positive response. However, these
results don’t have statistical significance too (p>0.05). The differences obtained between
the two controls (deionized water enriched with NaCl and deionized water with ascorbic
acid enriched with NaCl) were also not statistical significant (p>0.05) whereby it is not
possible to conclude something about the results from the stimuli in the head.
Comparing the effects caused by BDM and the effects caused by the DBPs it was
not observed significant differences (p>0.05) between the results at the end of the assay.
So, no conclusions can be drawn from this touch response test.
Table 5.1. Percentage of positive reactions to the mechanic stimuli applied in the tail and the
head of the larvae. Each experimental condition has two replications.
Positive reaction (%)
tail head
Autoclaved water 93,33 93,33
100 93,33
NaCl Ctrl 86,67 80
100 100
Ascorbic acid Ctrl 100 100
93,33 93,33
0.1 mg/l BDM 86,67 33,33
66,67 33,33
0.1 mg/L DBPs 60 40
73,33 60
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6. Conclusions
The present work had two major objectives: (i) the assess the stability of four UV-
filters commonly used in PCPs: benzyl salicylate (BzS), phenyl salicylate (PS), 4-methyl
benzilydene camphor (4-MBC) and octocrylene (OC) in chlorinated water, in conditions
similar to those existent in swimming pools, (a) evaluating their stability in water samples
with different pH values and different free chlorine conditions; (b) to determine their half-
lives; (c) tentatively identify major DBPs and (d) to study their stability under time, and (ii)
assess the toxicity of an UV-filter whose chlorination reaction already studied by Santos et
al. (Santos et al., 2013) (BDM) comparing the toxicity caused by the parental compound
(BDM) to the toxicity of its DBPs acutely exposing larvae of zebrafish (Danio rerio) to
several concentrations of BDM and corresponding DBPs solution resulting from
chlorination reaction. The effect of these compounds regarding mortality and anatomic
abnormalities was assessed.
6.1. Study of the reaction kinetics of BzS, PS, 4-MCB and OC in chlorinated
water
The kinetics of the reactions between the four UV-filters and chlorinated water, the
DBPs formation and the effect of sample pH and free chlorine concentration were studied
by HPLC-UV-DAD.
The studied salicylates (BzS and PS) react with chlorine leading to the formation of
DBPs. PS was found to be less stable in chlorine and we think this reactivity difference is
due to the possibility of a higher stabilization of the transition state of the electrophilic
substitution reaction. Regarding 4-MBC and OC the chlorination reaction occurs but not in
useful time.
DBPs of the two salicylates have been tentatively identified by HPLC-MS. Two
mono- and one dichlorinated by-product have been detected for both salicylates. In
contrast to what happens to the parental compounds, DBPs of BzS showed a good
stability while PS by-products were found to significantly degrade after 20 min reaction. It
was observed no DBPs for 4-MBC and OC.
To study the chlorination of the four UV-filters, free chlorine concentrations applied
were from 1 mg/L and 10 mg/L. These concentrations are acceptable in several places
around the world: free chlorine levels of less than 1 mg/L are acceptable in some
countries but, in other countries higher levels are considered acceptable. In public and
semi-public swimming pools and hot tubes it is acceptable levels of 3 mg/L and 5 mg/L of
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free chlorine, respectively. However, periodically, in some situations there are applied
concentrations up to 20 mg/L as a shock dose to better manage the microbial quality of
the water (WHO, 2006). The pH should be maintained between 7.2 and 8.0 (WHO, 2006).
So, in order to assess whether the two salicylates react to a significant extent with low
chlorine concentrations, such as those used in swimming pools, a set of experiments was
designed. The effect of three different pH (6.0, 7.0, 8.0) on the extent of the reaction
between the two salicylates and four concentrations of free chlorine (1, 2, 3 and 5 mg/L)
was studied separately for each salicylate. These experimental conditions were chosen
with the intent to include the conditions used in swimming pool and hot tubs and this study
was not applied to 4-MBC neither OC once these two UV-filters didn’t react with chlorine
in the previous one. It was possible to conclude that the extent of the reactions between
BzS and PS and free chlorine depends on the studied parameters: concentration of
chlorine and the pH of the water. It was observed that at pH 6.0 there is a small
transformation of both salicylates (maximum about 20%) and is almost independently from
free chlorine concentration. At pH 7.0 and 8.0 and for free chlorine concentrations from 2
to 5 mg/L the transformation percentage of BzS and PS increases with the increase of the
solution pH. This can be due to the fact that the anionic forms of the salicylates
(phenoxide anions) react faster with HOCl than the neutral forms with OCl- [pKHOCl,25ºC =
7.54, (Deborde and Von Gunten, 2008)]. We can also conclude that at higher pH values
PS reacts with chlorine in a higher extent than BzS.
6.2. Study of the degradation induced by UV radiation of 4-MBC and OC
Once the reaction with chlorine was not observed and to increase the knowledge
about the reactions suffered by 4-MBC and OC in swimming pool water, the degradation
induced by UV radiation was studied. It was verified that 4-MBC suffers isomerization
between the E-form and the Z-form when under both artificial and natural UV radiation.
This isomerization was already described by other authors (Giokas et al., 2007; Rodil et
al., 2009). The photostability of 4-MBC was already described (Gaspar and Maia Campos,
2006; Rodil et al., 2009) but here it was observed that, in presence of chlorine, the
concentration of the E-form was lower than its concentration in absence of chlorine, while
the concentration of the Z-form was similar with and without chlorine.
OC doesn’t suffers isomerization and, although the photostability of OC was also
already described (Giokas et al., 2007; Rodil et al., 2009; (Kockler et al., 2013), here it
was observed the slightly decrease of the concentration of OC along the reaction time
under natural UV radiation. The effect of chlorine was inconclusive since it was verified a
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lower concentration of OC in presence of chlorine under artificial UV filter but the
concentration under natural UV radiation was similar with and without chlorine.
6.3. Toxicological assays
Zebrafish is used as a toxicological model having several advantages for drug
screening (McGrath and Li, 2009). This organism is small, cheap to keep in the laboratory
and easily bred in large numbers. Larvae of zebrafish can live for seven days in a single
well of microplates and their nutritional requirement is almost provided by nutrients stored
in yolk sac. Zebrafish allows an easy administration of tested compounds because the
larvae can absorb small molecules diluted in the medium through their skin and gills.
Zebrafish has advantages comparing to other animal models since it is necessary small
amounts of the tested drug, a large number of specimens can be used in each assay, and
their organs and tissues (brain, heart, liver, pancreas, kidney, intestine, bones, muscles,
nerve system and sensory organs) are similar to their mammalian counterparts regarding
anatomical, physiological and molecular levels (McGrath and Li, 2009). The development
of the zebrafish embryo is very fast. The larvae start feeding 5 dpf suggesting that most
organs acquire a functional state at this time (Yang et al., 2009).
Zebrafish was already utilized as animal model to assess the toxicity of OC by
Blüthgen et al. (Blüthgen et al., 2014) in a chronic exposure.
Here, it can be concluded that the presence of nutrients is essential for larvae
survival and the concentration of NaCl used (5.03 mM) was enough to ensure the
nutritional requirements. Ascorbic acid was a good way to eliminate free chlorine from the
tested solutions and, although it was observed some skeletal deformations in the larvae
exposed to the controls of ascorbic acid (fourth assay), these results were not statistically
significant.
It was not possible to conclude if BDM and its DBPs at 1 mg/L have impact on the
larvae (second assay) although it was observed some abnormalities at 0.1 mg/L of DBPs
(third assay). On the other hand, BDM at lower concentrations (0.1 µg/L) (fourth assay)
caused mortality as well as DBPs at 0.1 µg/L, 1 µg/L and 10 µg/L. Usually, UV-filters have
a high lipophilicity (Díaz-Cruz and Barceló, 2009) and it was observed that, after the end
of the assays, the wells containing the BDM solutions showed an oily residue what may
indicate a poor solubility of BDM in the water. So, this poor solubility may explain the high
mortality caused at lower concentrations of BDM since at the higher concentration BDM
could not be completely dissolved forming film which is not contacted with the larvae.
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Regarding the touch response test, it was not observed significant differences
between the effects caused by BDM and the effects caused by the DBPs at the end of the
assay. Generally, the percentage of positive reactions of the stimuli applied in the tail was
higher than the percentage of positive reactions of the stimuli applied in the head (Table
5.1) During the development of the larvae, the movements of the tail appears first than the
movements of the head (Saint-Amant and Drapeau, 1998) so, it is normal that the
experimental conditions affect the escape response induced by a stimulus near the head
more than near the tail. It was also observed that all the larvae with some abnormality
have negative responses to these stimuli.
The concentrations used in these assays viewed to coincide with the levels of
UV-filters usually found in the environmental (Zhang and Lee, 2013). After an optimization
process it was possible test concentrations raging µg/L. However, due to the method used
to obtain the DBPs, it was not possible ensure that the real concentration of DBPs present
in the solutions was the calculated. The fact that the concentration decreases along the
time is another reason to not be possible to ensure that the concentrations were the
expected. Now, it is important to develop methods to optimize the determination of the
real concentrations.
In the natural ecosystems, the organisms are exposed to mixtures of many
compounds whereby the effects observed may be synergistic even when the individual
compounds are present at no observable effect concentrations (NOECs) (Díaz-Cruz and
Barceló, 2009). As sunscreens are applied containing several UV-filters, it is critical to
assess their activity in mixture combinations (Díaz-Cruz and Barceló, 2009).
Future work should investigate the presence of these DBPs in swimming pool
water and waste water, address potential risks for human health due to dermal contact
and evaluate possible environmental toxic effects. Environmental chemistry studies
should also focus on strategies to minimize the formation of these DBPs by the
development of new formulations that prevent PPCPs release into chlorinated water and
strategies to reduce PPCPs by pool water treatment and by pre-swim showering.
From the point of view of the water quality of swimming pools where the PPCPs
used by swimmers are released to water this work is quite relevant because these PPCPs
and their transformation products accumulate in the bathing water rising human health
concerns. Environmental risk can also arise after discharge of the swimming pool effluents
into the aquatic systems.
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Appendix A.1. Percentage of mortality (left column) and abnormalities (right column) in zebrafish
caused by different conditions per well along all the days of the second assay and corresponding
results from statistical analysis (One-way ANOVA).
BDM BDPs BDM BDPs
1 0 0 0 0
2 0 0 0 0
3 0 20 0 0
BDPs 0.30 ppm Cl Ctrl BDPs 0.30 ppm Cl Ctrl
1 0 0 0 0
2 0 0 0 0
3 20 0 0 0
BDM BDPs BDM BDPs
1 0 0 0 60
2 0 0 0 0
3 0 0 0 0
BDPs 0.30 ppm Cl Ctrl BDPs 0.30 ppm Cl Ctrl
1 0 0 60 20
2 0 0 0 20
3 20 0 0 0
BDM BDPs BDM BDPs
1 0 0 0 40
2 0 0 0 0
3 0 0 0 0
BDPs 0.30 ppm Cl Ctrl BDPs 0.30 ppm Cl Ctrl
1 0 0 40 20
2 0 0 0 0
3 20 0 0 0
Mortality  (%) Abnormalinities (%)
BDM/BDPs
BDM/BDPs
BDPs/0.30 ppm
Cl Ctrl
2º day
3º day
BDPs/0.30 ppm
Cl Ctrl
4º day
BDM/BDPs
BDPs/0.30 ppm
Cl Ctrl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 20 6,666667 133,3333 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 66,66667 1 66,66667 1 0,373901 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 266,6667 4 66,66667 Within Groups 0 4 0
Total 333,3333 5 Total 0 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 20 6,666667 133,3333 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 66,66667 1 66,66667 1 0,373901 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 266,6667 4 66,66667 Within Groups 0 4 0
Total 333,3333 5 Total 0 5
Mortality Abnormalities
2º day
BDM/BDP
s
BDPs/0.30
ppm Cl
Ctrl.
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 60 20 1200
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 600 1 600 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 2400 4 600
Total 0 5 Total 3000 5
Anova: factor único Anova: Single Factor
SUMÁRIO SUMMARY
Grupos Contagem Soma Méday Variância Groups Count Sum Average Variance
Coluna 1 3 20 6,666667 133,3333 Column 1 3 60 20 1200
Coluna 2 3 0 0 0 Column 2 3 40 13,33333 133,3333
ANOVA ANOVA
Fonte de variação SQ gl MQ F valor P F crítico Source of Variation SS df MS F P-value F crit
Entre grupos 66,66667 1 66,66667 1 0,373901 7,708647 Between Groups 66,66667 1 66,66667 0,1 0,767644 7,708647
Dentro de grupos 266,6667 4 66,66667 Within Groups 2666,667 4 666,6667
Total 333,3333 5 Total 2733,333 5
3º day
BDM/BDP
s
BDPs/0.30
ppm Cl
Ctrl.
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 40 13,33333 533,3333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 266,6667 1 266,6667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 1066,667 4 266,6667
Total 0 5 Total 1333,333 5
Anova: factor único Anova: Single Factor
SUMÁRIO SUMMARY
Grupos Contagem Soma Méday Variância Groups Count Sum Average Variance
Coluna 1 3 20 6,666667 133,3333 Column 1 3 40 13,33333 533,3333
Coluna 2 3 0 0 0 Column 2 3 20 6,666667 133,3333
ANOVA ANOVA
Fonte de variação SQ gl MQ F valor P F crítico Source of Variation SS df MS F P-value F crit
Entre grupos 66,66667 1 66,66667 1 0,373901 7,708647 Between Groups 66,66667 1 66,66667 0,2 0,677869 7,708647
Dentro de grupos 266,6667 4 66,66667 Within Groups 1333,333 4 333,3333
Total 333,3333 5 Total 1400 5
4º day
BDM/BDP
s
BDPs/0.30
ppm Cl
Ctrl.
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 0 5 Total 0 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 0 5 Total 0 5
2º day
Ctrl Cl 0.3
ppm/0.30
ppm Cl +
NaCl Ctrl
NaCl
Ctrl/Autoc
laved
water
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 100 33,33333 933,3333
Column 2 3 0 0 0 Column 2 3 40 13,33333 133,3333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 600 1 600 1,125 0,348641 7,708647
Within Groups 0 4 0 Within Groups 2133,333 4 533,3333
Total 0 5 Total 2733,333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 0 5 Total 0 5
3º day
Ctrl Cl 0.3
ppm/0.30
ppm Cl +
NaCl Ctrl
NaCl
Ctrl/Autoc
laved
water
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666667 133,3333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66667
Total 0 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666667 133,3333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66667
Total 0 5 Total 333,3333 5
4º day
Ctrl Cl 0.3
ppm/0.30
ppm Cl +
NaCl Ctrl
NaCl
Ctrl/Autoc
laved
water
114
Appendix A.2. Percentage of mortality (left column) and abnormalities (right column) in zebrafish
caused by different conditions per well along all the days of the third assay and corresponding
results from statistical analysis (One-way ANOVA).
BDM DBPs BDM DBPs
1 0 0 0 0
2 0 0 20 6,67
w/o Ascorbic
Acid w/ Ascorbic Acid w/o Ascorbic Acid w/ Ascorbic Acid
1 0 0 0 0
2 0 0 0 0
BDM DBPs BDM DBPs
1 0 0 0 0
2 0 0 6,67 0
w/o Ascorbic
Acid w/ Ascorbic Acid w/o Ascorbic Acid w/ Ascorbic Acid
1 0 0 6,67 0
2 0 0 0 0
BDM DBPs BDM DBPs
1 0 0 60 0
2 0 0 60 0
w/o Ascorbic
Acid w/ Ascorbic Acid w/o Ascorbic Acid w/ Ascorbic Acid
1 0 0 6,67 0
2 0 0 0 0
BDM DBPs BDM DBPs
1 0 0 13,33 0
2 0 0 13,33 0
w/o Ascorbic
Acid w/ Ascorbic Acid w/o Ascorbic Acid w/ Ascorbic Acid
1 0 0 6,67 0
2 0 0 0 0
BDM/DBPs
H2O
BDM/DBPs
Autoclaved water
Mortality (%) Abnormalities (%)
2º day
3º day
BDM/DBPs
H2O
4º day
BDM/DBPs
H2O
5º day
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 20 10 200
Column 2 2 0 0 0 Column 2 2 6,67 3,335 22,24445
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 44,42223 1 44,42223 0,39976 0,591854 18,51282
Within Groups 0 2 0 Within Groups 222,2445 2 111,1222
Total 0 3 Total 266,6667 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 0 0 0
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 0 1 0 65535 #DIV/0! 18,51282
Within Groups 0 2 0 Within Groups 0 2 0
Total 0 3 Total 0 3
BDM/DBP
s
Ascorbic
Acid
2º day
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 6,67 3,335 22,24445
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 11,12223 1 11,12223 1 0,42265 18,51282
Within Groups 0 2 0 Within Groups 22,24445 2 11,12223
Total 0 3 Total 33,36668 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 6,67 3,335 22,24445
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 11,12223 1 11,12223 1 0,42265 18,51282
Within Groups 0 2 0 Within Groups 22,24445 2 11,12223
Total 0 3 Total 33,36668 3
3º day
BDM/DBP
s
Ascorbic
Acid
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 120 60 0
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 3600 1 3600 65535 #DIV/0! 18,51282
Within Groups 0 2 0 Within Groups 0 2 0
Total 0 3 Total 3600 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 6,67 3,335 22,24445
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 11,12223 1 11,12223 1 0,42265 18,51282
Within Groups 0 2 0 Within Groups 22,24445 2 11,12223
Total 0 3 Total 33,36668 3
4º day
BDM/DBP
s
Ascorbic
Acid
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 26,66 13,33 0
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 177,6889 1 177,6889 65535 #DIV/0! 18,51282
Within Groups 0 2 0 Within Groups 0 2 0
Total 0 3 Total 177,6889 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 6,67 3,335 22,24445
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 11,12223 1 11,12223 1 0,42265 18,51282
Within Groups 0 2 0 Within Groups 22,24445 2 11,12223
Total 0 3 Total 33,36668 3
5º day
BDM/DBP
s
Ascorbic
Acid
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BDM NaCl Ctrl BDM NaCl Ctrl
1 0 0 0 0
2 0 0 20 0
DBPs Ascorbic acid +NaCl Ctrl DBPs
Ascorbic acid +
NaCl Ctrl
1 0 0 6,67 0
2 0 0 0 0
BDM NaCl Ctrl BDM NaCl Ctrl
1 0 0 0 6,67
2 0 0 6,67 0
DBPs Ascorbic acid +NaCl Ctrl DBPs
Ascorbic acid +
NaCl Ctrl
1 0 0 0 0
2 0 0 0 0
BDM NaCl Ctrl BDM NaCl Ctrl
1 0 0 60 6,67
2 0 0 60 0
DBPs Ascorbic acid +NaCl Ctrl DBPs
Ascorbic acid +
NaCl Ctrl
1 0 0 0 0
2 0 0 0 0
BDM NaCl Ctrl BDM NaCl Ctrl
1 0 0 13,33 6,67
2 0 0 13,33 0
DBPs Ascorbic acid +NaCl Ctrl DBPs
Ascorbic acid +
NaCl Ctrl
1 0 0 0 0
2 0 0 0 0
Mortality (%)
5º day
BDM/NaCl Ctrl
DBPs/Ascorbic acid + NaCl Ctrl
Abnormalities (%)
2º day
BDM/NaCl Ctrl
DBPs/Ascorbic acid + NaCl Ctrl
3º day
BDM/NaCl Ctrl
DBPs/Ascorbic acid + NaCl Ctrl
4º day
BDM/NaCl Ctrl
DBPs/Ascorbic acid + NaCl Ctrl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 20 10 200
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 100 1 100 1 0,42265 18,51282
Within Groups 0 2 0 Within Groups 200 2 100
Total 0 3 Total 300 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 6,67 3,335 22,24445
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 11,12223 1 11,12223 1 0,42265 18,51282
Within Groups 0 2 0 Within Groups 22,24445 2 11,12223
Total 0 3 Total 33,36668 3
2º day
BDM/NaCl
Ctrl
DBPs/Asc
orbic acid
+ NaCl Ctrl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 6,67 3,335 22,24445
Column 2 2 0 0 0 Column 2 2 6,67 3,335 22,24445
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 0 1 0 0 1 18,51282
Within Groups 0 2 0 Within Groups 44,4889 2 22,24445
Total 0 3 Total 44,4889 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 0 0 0
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 0 1 0 65535 #DIV/0! 18,51282
Within Groups 0 2 0 Within Groups 0 2 0
Total 0 3 Total 0 3
3º day
BDM/NaCl
Ctrl
DBPs/Asc
orbic acid
+ NaCl Ctrl
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 120 60 0
Column 2 2 0 0 0 Column 2 2 6,67 3,335 22,24445
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 3210,922 1 3210,922 288,6942 0,003446 18,51282
Within Groups 0 2 0 Within Groups 22,24445 2 11,12223
Total 0 3 Total 3233,167 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 0 0 0
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 0 1 0 65535 #DIV/0! 18,51282
Within Groups 0 2 0 Within Groups 0 2 0
Total 0 3 Total 0 3
4º day
BDM/NaCl
Ctrl
DBPs/Asc
orbic acid
+ NaCl Ctrl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 26,66 13,33 0
Column 2 2 0 0 0 Column 2 2 6,67 3,335 22,24445
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 99,90003 1 99,90003 8,982018 0,095631 18,51282
Within Groups 0 2 0 Within Groups 22,24445 2 11,12223
Total 0 3 Total 122,1445 3
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 2 0 0 0 Column 1 2 0 0 0
Column 2 2 0 0 0 Column 2 2 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 18,51282 Between Groups 0 1 0 65535 #DIV/0! 18,51282
Within Groups 0 2 0 Within Groups 0 2 0
Total 0 3 Total 0 3
5º day
BDM/NaCl
Ctrl
DBPs/Asc
orbic acid
+ NaCl Ctrl
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Appendix A.3. Percentage of mortality (left column) and abnormalities (right column) in zebrafish
caused by different conditions per well along all the days of the fourth assay and corresponding
results from statistical analysis (One-way ANOVA).
10 ug/L 1 ug/L 0.1 ug/L 10 ug/L 1 ug/L 0.1 ug/L
1 0 0 0 0 0 20
2 0 0 20 0 20 0
3 0 0 20 0 20 20
1 100 80 0 0 0 20
2 100 100 0 0 0 60
3 100 60 0 0 0 20
w/o Ascorbic acid w/ Ascorbic acid w/o Ascorbicacid w/ Ascorbic acid
1 0 60 0 20
2 0 40 0 0
3 0 0 0 20
10 ug/L 1 ug/L 0.1 ug/L 10 ug/L 1 ug/L 0.1 ug/L
1 0 0 100 0 0 0
2 0 0 100 0 0 0
3 0 0 80 0 0 0
1 100 80 0 0 0 20
2 100 100 0 0 0 60
3 100 60 0 0 0 20
w/o Ascorbic acid w/ Ascorbic acid w/o Ascorbicacid w/ Ascorbic acid
1 0 60 0 20
2 0 40 0 0
3 0 0 0 20
10 ug/L 1 ug/L 0.1 ug/L 10 ug/L 1 ug/L 0.1 ug/L
1 0 0 100 20 0 0
2 0 0 100 0 0 0
3 0 0 80 0 0 0
1 100 80 20 0 0 20
2 100 100 60 0 0 60
3 100 60 20 0 0 20
w/o Ascorbic acid w/ Ascorbic acid w/o Ascorbicacid w/ Ascorbic acid
1 0 80 0 0
2 0 60 0 0
3 0 20 20 0
10 ug/L 1 ug/L 0.1 ug/L 10 ug/L 1 ug/L 0.1 ug/L
1 0 0 100 20 0 0
2 0 0 100 0 0 0
3 0 0 80 0 0 20
1 100 100 100 0 0 0
2 100 100 100 0 0 0
3 100 100 100 0 0 0
w/o Ascorbic acid w/ Ascorbic acid w/o Ascorbicacid w/ Ascorbic acid
1 0 0 80 0
2 0 0 100 0
3 0 0 20 0
3º day
BDM
DBPs
Autoclaved water
4º day
BDM
DBPs
Autoclaved water
Autoclaved water
2º day
Abnormalities (%)
DBPs
BDM
Mortality (%)
DBPs
Autoclaved water
5º day
BDM
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 40 13,33333333 133,3333333
Column 3 3 40 13,33333333 133,3333333 Column 3 3 40 13,33333333 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 355,5555556 2 177,7777778 4 0,078717201 5,14325285 Between Groups 355,5555556 2 177,7777778 2 0,216 5,14325285
Within Groups 266,6666667 6 44,44444444 Within Groups 533,3333333 6 88,88888889
Total 622,2222222 8 Total 888,8888889 8
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 240 80 400 Column 2 3 0 0 0
Column 3 3 0 0 0 Column 3 3 100 33,33333333 533,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 16800 2 8400 63 9,39144E-05 5,14325285 Between Groups 2222,222222 2 1111,111111 6,25 0,03411 5,14325285
Within Groups 800 6 133,3333333 Within Groups 1066,666667 6 177,7777778
Total 17600 8 Total 3288,888889 8
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 100 33,33333333 933,3333333 Column 2 3 40 13,33333333 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 1666,666667 1 1666,666667 3,571428571 0,131777567 7,70864742 Between Groups 266,6666667 1 266,6666667 4 0,11612 7,70864742
Within Groups 1866,666667 4 466,6666667 Within Groups 266,6666667 4 66,66666667
Total 3533,333333 5 Total 533,3333333 5
Ascorbic
acid Ctrl
2º day
BDM
DBPs
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
Column 3 3 280 93,33333333 133,3333333 Column 3 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 17422,22222 2 8711,111111 196 3,42614E-06 5,14325285 Between Groups 0 2 0 65535 #DIV/0! 5,14325285
Within Groups 266,6666667 6 44,44444444 Within Groups 0 6 0
Total 17688,88889 8 Total 0 8
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 240 80 400 Column 2 3 0 0 0
Column 3 3 0 0 0 Column 3 3 100 33,33333333 533,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 16800 2 8400 63 9,39144E-05 5,14325285 Between Groups 2222,222222 2 1111,111111 6,25 0,03411 5,14325285
Within Groups 800 6 133,3333333 Within Groups 1066,666667 6 177,7777778
Total 17600 8 Total 3288,888889 8
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 100 33,33333333 933,3333333 Column 2 3 40 13,33333333 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 1666,666667 1 1666,666667 3,571428571 0,131777567 7,70864742 Between Groups 266,6666667 1 266,6666667 4 0,11612 7,70864742
Within Groups 1866,666667 4 466,6666667 Within Groups 266,6666667 4 66,66666667
Total 3533,333333 5 Total 533,3333333 5
3º day
BDM
DBPs
Ascorbic
acid Ctrl
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 20 6,666666667 133,3333333
Column 2 3 0 0 0 Column 2 3 0 0 0
Column 3 3 280 93,33333333 133,3333333 Column 3 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 17422,22222 2 8711,111111 196 3,42614E-06 5,14325285 Between Groups 88,88888889 2 44,44444444 1 0,42187 5,14325285
Within Groups 266,6666667 6 44,44444444 Within Groups 266,6666667 6 44,44444444
Total 17688,88889 8 Total 355,5555556 8
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 240 80 400 Column 2 3 0 0 0
Column 3 3 100 33,33333333 533,3333333 Column 3 3 100 33,33333333 533,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 7022,222222 2 3511,111111 11,28571429 0,009261 5,14325285 Between Groups 2222,222222 2 1111,111111 6,25 0,03411 5,14325285
Within Groups 1866,666667 6 311,1111111 Within Groups 1066,666667 6 177,7777778
Total 8888,888889 8 Total 3288,888889 8
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 20 6,666666667 133,3333333
Column 2 3 160 53,33333333 933,3333333 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 4266,666667 1 4266,666667 9,142857143 0,039020527 7,70864742 Between Groups 66,66666667 1 66,66666667 1 0,3739 7,70864742
Within Groups 1866,666667 4 466,6666667 Within Groups 266,6666667 4 66,66666667
Total 6133,333333 5 Total 333,3333333 5
4º day
BDM
DBPs
Ascorbic
acid Ctrl
Anova: factor único Anova: factor único
SUMÁRIO SUMÁRIO
Grupos Contagem Soma Méday Variância Grupos Contagem Soma Méday Variância
Coluna 1 3 0 0 0 Coluna 1 3 20 6,666666667 133,3333333
Coluna 2 3 0 0 0 Coluna 2 3 0 0 0
Coluna 3 3 280 93,33333333 133,3333333 Coluna 3 3 20 6,666666667 133,3333333
ANOVA ANOVA
Fonte de variação SQ gl MQ F valor P F crítico Fonte de variação SQ gl MQ F valor P F crítico
Entre grupos 17422,22222 2 8711,111111 196 3,42614E-06 5,14325285 Entre grupos 88,88888889 2 44,44444444 0,5 0,62974 5,14325285
Dentro de grupos 266,6666667 6 44,44444444 Dentro de grupos 533,3333333 6 88,88888889
Total 17688,88889 8 Total 622,2222222 8
Anova: factor único Anova: factor único
SUMÁRIO SUMÁRIO
Grupos Contagem Soma Méday Variância Grupos Contagem Soma Méday Variância
Coluna 1 3 300 100 0 Coluna 1 3 20 6,666666667 133,3333333
Coluna 2 3 300 100 0 Coluna 2 3 0 0 0
Coluna 3 3 300 100 0 Coluna 3 3 20 6,666666667 133,3333333
ANOVA ANOVA
Fonte de variação SQ gl MQ F valor P F crítico Fonte de variação SQ gl MQ F valor P F crítico
Entre grupos 0 2 0 65535 #DIV/0! 5,14325285 Entre grupos 88,88888889 2 44,44444444 0,5 0,62974 5,14325285
Dentro de grupos 0 6 0 Dentro de grupos 533,3333333 6 88,88888889
Total 0 8 Total 622,2222222 8
Anova: factor único Anova: factor único
SUMÁRIO SUMÁRIO
Grupos Contagem Soma Méday Variância Grupos Contagem Soma Méday Variância
Coluna 1 3 0 0 0 Coluna 1 3 200 66,66666667 1733,333333
Coluna 2 3 0 0 0 Coluna 2 3 0 0 0
ANOVA ANOVA
Fonte de variação SQ gl MQ F valor P F crítico Fonte de variação SQ gl MQ F valor P F crítico
Entre grupos 0 1 0 65535 #DIV/0! 7,70864742 Entre grupos 6666,666667 1 6666,666667 7,692307692 0,05015 7,70864742
Dentro de grupos 0 4 0 Dentro de grupos 3466,666667 4 866,6666667
Total 0 5 Total 10133,33333 5
5º day
BDM
DBPs
Ascorbic
acid Ctrl
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BDM H2O NaCl BDM H2O NaCl
1 0 0 20 0
2 20 0 0 0
3 20 0 20 0
1 0 0 0 0
2 0 0 20 0
3 0 0 20 0
BDM H2O NaCl BDM H2O NaCl
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
BDM H2O NaCl BDM H2O NaCl
1 100 0 0 0
2 100 0 0 0
3 80 0 0 20
1 0 0 0 0
2 0 0 0 0
3 0 0 0 20
BDM H2O NaCl BDM H2O NaCl
1 0 0 0 0
2 0 0 0 0
3 0 0 0 20
BDM H2O NaCl BDM H2O NaCl
1 100 0 0 0
2 100 0 0 0
3 80 0 0 20
1 0 0 0 0
2 0 0 0 0
3 0 0 0 20
BDM H2O NaCl BDM H2O NaCl
1 0 0 20 0
2 0 0 0 0
3 0 0 0 20
BDM H2O NaCl BDM H2O NaCl
1 100 0 0 0
2 100 0 0 0
3 80 0 20 0
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
BDM H2O NaCl BDM H2O NaCl
1 0 0 20 0
2 0 0 0 0
3 0 0 0 0
Mortality (%) Abnormalities (%)
2º day
0,1 mg/L BDM/H2O
NaCl
1 mg/L BDM/H2O NaCl
10 mg/L BDM/H2O
NaCl
5º day
0,1 mg/L BDM/H2O
NaCl
1 mg/L BDM/H2O NaCl
10 mg/L BDM/H2O
NaCl
3º day
0,1 mg/L BDM/H2O
NaCl
1 mg/L BDM/H2O NaCl
10 mg/L BDM/H2O
NaCl
4º day
0,1 mg/L BDM/H2O
NaCl
1 mg/L BDM/H2O NaCl
10 mg/L BDM/H2O
NaCl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 40 13,33333 133,3333 Column 1 3 40 13,33333333 133,3333333
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 266,6667 1 266,6667 4 0,116116524 7,708647 Between Groups 266,6667 1 266,6666667 4 0,116117 7,708647
Within Groups 266,6667 4 66,66667 Within Groups 266,6667 4 66,66666667
Total 533,3333 5 Total 533,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 40 13,33333333 133,3333333
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 266,6667 1 266,6666667 4 0,116117 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66666667
Total 0 5 Total 533,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 0 5 Total 0 5
2º day
0,1 mg/L
BDM/NaCl Ctrl
1 mg/L BDM/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 280 93,33333 133,3333 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 13066,67 1 13066,67 196 0,000151011 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 266,6667 4 66,66667 Within Groups 266,6667 4 66,66666667
Total 13333,33 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66666667
Total 0 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66666667
Total 0 5 Total 333,3333 5
3º day
0,1 mg/L
BDM/NaCl Ctrl
1 mg/L BDM/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 280 93,33333 133,3333 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 13066,67 1 13066,67 196 0,000151011 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 266,6667 4 66,66667 Within Groups 266,6667 4 66,66666667
Total 13333,33 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66666667
Total 0 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 20 6,666666667 133,3333333
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 0 1 0 0 1 7,708647
Within Groups 0 4 0 Within Groups 533,3333 4 133,3333333
Total 0 5 Total 533,3333 5
4º day
0,1 mg/L
BDM/NaCl Ctrl
1 mg/L BDM/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
123
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 280 93,33333 133,3333 Column 1 3 20 6,666666667 133,3333333
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 13066,67 1 13066,67 196 0,000151011 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 266,6667 4 66,66667 Within Groups 266,6667 4 66,66666667
Total 13333,33 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 0 5 Total 0 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 0 0 0 Column 1 3 20 6,666666667 133,3333333
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 0 1 0 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66666667
Total 0 5 Total 333,3333 5
5º day
0,1 mg/L
BDM/NaCl Ctrl
1 mg/L BDM/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
DBPs H2O NaCl DBPs H2O NaCl
1 0 0 20 0
2 0 0 60 0
3 0 0 20 0
1 80 0 0 0
2 100 0 0 0
3 60 0 0 0
DBPs H2O NaCl DBPs H2O NaCl
1 100 0 0 0
2 100 0 0 0
3 100 0 0 0
DBPs NaCl Ctrl DBPs NaCl Ctrl
1 20 0 0 0
2 60 0 60 0
3 20 0 20 20
1 80 0 0 0
2 100 0 0 0
3 60 0 0 20
DBPs NaCl Ctrl DBPs NaCl Ctrl
1 100 0 0 0
2 100 0 0 0
3 100 0 0 20
DBPs NaCl Ctrl DBPs NaCl Ctrl
1 20 0 20 0
2 60 0 60 0
3 20 0 20 20
1 80 0 0 0
2 100 0 0 0
3 60 0 0 20
DBPs NaCl Ctrl DBPs NaCl Ctrl
1 100 0 0 0
2 100 0 0 0
3 100 0 0 20
DBPs NaCl Ctrl DBPs NaCl Ctrl
1 100 0 0 0
2 100 0 0 0
3 100 0 0 0
1 100 0 0 0
2 100 0 0 0
3 100 0 0 0
DBPs NaCl Ctrl DBPs NaCl Ctrl
1 100 0 0 0
2 100 0 0 0
3 100 0 0 0
3º day
5º day
0,1 mg/L DBPs/NaCl
Ctrl
1 mg/L DBPs/NaCl Ctrl
10 mg/L DBPs/NaCl
Ctrl
Mortality (%) Abnormalities (%)
2º day
0,1 mg/L DBPs/NaCl
Ctrl
1 mg/L DBPs/NaCl Ctrl
10 mg/L DBPs/NaCl
Ctrl
0,1 mg/L DBPs/NaCl
Ctrl
1 mg/L DBPs/NaCl Ctrl
10 mg/L DBPs/NaCl
Ctrl
4º day
0,1 mg/L DBPsNaCl Ctrl
1 mg/L DBPs/NaCl Ctrl
10 mg/L DBPs/NaCl
Ctrl
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 100 33,33333 533,3333 Column 1 3 100 33,33333333 533,3333333
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 1666,667 1 1666,667 6,25 0,066766545 7,708647 Between Groups 1666,667 1 1666,666667 6,25 0,066767 7,708647
Within Groups 1066,667 4 266,6667 Within Groups 1066,667 4 266,6666667
Total 2733,333 5 Total 2733,333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 240 80 400 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 9600 1 9600 48 0,002278426 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 800 4 200 Within Groups 0 4 0
Total 10400 5 Total 0 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 15000 1 15000 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 15000 5 Total 0 5
2º day
0,1 mg/L
DBPs/NaCl Ctrl
1 mg/L DBPs/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 100 33,33333 533,3333 Column 1 3 80 26,66666667 933,3333333
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 1666,667 1 1666,667 6,25 0,066766545 7,708647 Between Groups 600 1 600 1,125 0,348641 7,708647
Within Groups 1066,667 4 266,6667 Within Groups 2133,333 4 533,3333333
Total 2733,333 5 Total 2733,333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 240 80 400 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 9600 1 9600 48 0,002278426 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 800 4 200 Within Groups 266,6667 4 66,66666667
Total 10400 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 15000 1 15000 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66666667
Total 15000 5 Total 333,3333 5
3º day
0,1 mg/L
DBPs/NaCl Ctrl
1 mg/L DBPs/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
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Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 100 33,33333 533,3333 Column 1 3 100 33,33333333 533,3333333
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 1666,667 1 1666,667 6,25 0,066766545 7,708647 Between Groups 1066,667 1 1066,666667 3,2 0,148148 7,708647
Within Groups 1066,667 4 266,6667 Within Groups 1333,333 4 333,3333333
Total 2733,333 5 Total 2400 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 240 80 400 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 9600 1 9600 48 0,002278426 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 800 4 200 Within Groups 266,6667 4 66,66666667
Total 10400 5 Total 333,3333 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 20 6,666666667 133,3333333
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 15000 1 15000 65535 #DIV/0! 7,708647 Between Groups 66,66667 1 66,66666667 1 0,373901 7,708647
Within Groups 0 4 0 Within Groups 266,6667 4 66,66666667
Total 15000 5 Total 333,3333 5
4º day
0,1 mg/L
DBPs/NaCl Ctrl
1 mg/L DBPs/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 15000 1 15000 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 15000 5 Total 0 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 15000 1 15000 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 15000 5 Total 0 5
Anova: Single Factor Anova: Single Factor
SUMMARY SUMMARY
Groups Count Sum Average Variance Groups Count Sum Average Variance
Column 1 3 300 100 0 Column 1 3 0 0 0
Column 2 3 0 0 0 Column 2 3 0 0 0
ANOVA ANOVA
Source of Variation SS df MS F P-value F crit Source of Variation SS df MS F P-value F crit
Between Groups 15000 1 15000 65535 #DIV/0! 7,708647 Between Groups 0 1 0 65535 #DIV/0! 7,708647
Within Groups 0 4 0 Within Groups 0 4 0
Total 15000 5 Total 0 5
5º day
0,1 mg/L
DBPs/NaCl Ctrl
1 mg/L DBPs/NaCl
Ctrl
10 mg/L
DBPs/NaCl Ctrl
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Appendix A.4. Percentage of positive responses in tail (left column) and in head (right column) in
zebrafish durinh the touch response test in zebrafish exposed to different conditions and
corresponding results from statistical analysis (One-way ANOVA).
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